-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Eh+JOd1eq6r/z+MV+qep6/D9GF1hijHbaggXDMUdHt28fvBYX841JnwlL5S4k9xv
 f/CJgIHJWjMKhPtGDEEW+g==

<SEC-DOCUMENT>0000927946-05-000010.txt : 20050119
<SEC-HEADER>0000927946-05-000010.hdr.sgml : 20050119
<ACCEPTANCE-DATETIME>20050119133144
ACCESSION NUMBER:		0000927946-05-000010
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20040930
FILED AS OF DATE:		20050119
DATE AS OF CHANGE:		20050119
EFFECTIVENESS DATE:		20050119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		05535722

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>proxystatementarial.htm
<DESCRIPTION>PROXY STATEMENT
<TEXT>


<HTML>
<HEAD>
<TITLE>Proxy Statement for Bioanalytical Systems, Inc.</TITLE>
</HEAD>
<BODY>

<BR>
<BR>
<BR>
<BR>

<P ALIGN=CENTER><FONT FACE="Arial Narrow" SIZE="2">
<IMG SRC="basilogo.gif"></FONT></P>
<BR>
<BR>
<BR>
<BR>



<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A001></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
Shareholders of Bioanalytical Systems, Inc.:</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>You are
invited to attend the Annual Meeting of Shareholders of Bioanalytical Systems,
Inc. (&#147;BASi&#148;) to be held Thursday, February 17, 2005, at 10:00 a.m.
(EST) at BASi headquarters located at 2701 Kent Avenue, West Lafayette,
Indiana.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>At the
meeting, shareholders will vote on the election of seven persons to the Board of
Directors, and the authorization to reserve additional shares under the
Company&#146;s Employee and Director Stock Option Plans. Details can be found in
the accompanying Notice of Annual Meeting and Proxy Statement.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>We hope you
are able to attend the Annual Meeting personally, and we look forward to meeting
with you. Whether or not you currently plan to attend, please complete, date and
return the proxy card in the enclosed envelope. The vote of each shareholder is
very important. You may revoke your proxy at any time before it is voted by
giving written notice to the Secretary of BASi, by filing a properly executed
proxy bearing a later date or by attending the Annual Meeting and voting in
person.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>On behalf of
the Board of Directors and management of BASi, I sincerely thank you for your
continued support.</FONT></P>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=40%><FONT FACE="Arial Narrow"SIZE=2>
Sincerely,<BR>
<BR>
Bioanalytical Systems, Inc.<BR>
<BR>
<IMG SRC="kissingersign.gif"><BR>
<BR>
Peter T. Kissinger, Ph.D.<BR>
Chairman, President and Chief Executive Officer<BR>
</font></TD>
</TR>
</TABLE>
<BR>









<PAGE>




<!-- MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Workstation" -->
<A NAME=A006></A>
<P ALIGN=CENTER>
<FONT FACE="Arial Narrow Bold" SIZE="3">
<IMG SRC="basilogo.gif"><BR>
BIOANALYTICAL SYSTEMS, INC.<BR>
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS<BR>
TO BE HELD FEBRUARY 17, 2005</FONT></P>
<BR>
<BR>
<BR>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A010></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>To Shareholders of Bioanalytical Systems, Inc.:</B></FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The Annual
Meeting of Shareholders of Bioanalytical Systems, Inc. (&#147;BASi&#148;) will
be held at the principal executive offices of BASi, at 2701 Kent Avenue, West
Lafayette, Indiana 47906 on Thursday, February 17, 2005 at 10:00 a.m. (EST) for
the following purposes:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Hang LV 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>(a)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Arial Narrow"SIZE=2>To
elect directors of BASi to serve for a one-year term; </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para (List) Hang LV 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>(b)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Arial Narrow"SIZE=2>to
approve amendment of the 1997 Employee Incentive Stock Option Plan to increase the number
of shares available for option grants; </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para (List) Hang LV 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>(c)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Arial Narrow"SIZE=2>to
approve amendment of the 1997 Outside Director Stock Option Plan to increase the number
of shares available for option grants; and </FONT></TD>
</TR>
</TABLE>
<BR>



<!-- MARKER FORMAT-SHEET="Para (List) Hang LV 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>(d)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Arial Narrow"SIZE=2>to
transact such other business as may properly come before the meeting.</FONT></TD>
</TR>
</TABLE>
<BR>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
Holders of BASi common shares of record at the close of business on December 31,
2004 are entitled to notice of, and to vote at, the Annual Meeting.</FONT></P>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=40%><FONT FACE="Arial Narrow"SIZE=2>
By Order of the Board of Directors,<BR>
<BR>
<IMG SRC="candicesign.gif"><BR>
<BR>
Candice B. Kissinger<BR>
Secretary<BR>
<BR>
<BR>
January 17, 2005<BR>
West Lafayette, Indiana</font></TD>
</TR>
</TABLE>
<BR>
<BR>
<BR>
<BR>
<BR>
<BR>



<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
YOUR VOTE IS IMPORTANT. IF YOU DO NOT EXPECT TO ATTEND THE ANNUAL MEETING, OR IF
YOU DO PLAN TO ATTEND BUT WISH TO VOTE BY PROXY, PLEASE DATE, SIGN AND PROMPTLY
MAIL THE ENCLOSED PROXY. A RETURN ENVELOPE IS PROVIDED FOR THIS
PURPOSE.</FONT></P>






<PAGE>





<!-- MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Default" -->
<A NAME=A014></A>
<P ALIGN=CENTER>
<FONT FACE="Arial Narrow"SIZE=2>
<IMG SRC="basilogo.gif"><BR>
<B>BIOANALYTICAL SYSTEMS, INC.<BR>
PROXY STATEMENT<BR>
ANNUAL MEETING OF SHAREHOLDERS<BR>
TO BE HELD FEBRUARY 17, 2005</B></FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A016></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>G<small>ENERAL</small> I<small>NFORMATION</small></B><BR>
This proxy statement is furnished in connection with the solicitation by the
Board of Directors of BASi of proxies to be voted at the Annual Meeting of
Shareholders to be held at 10:00 a.m. (EST) on Thursday, February 17, 2005, and
at any adjournment thereof. The meeting will be held at the principal executive
offices of BASi, 2701 Kent Avenue, West Lafayette, Indiana 47906. This proxy
statement and the accompanying form of proxy were first mailed to shareholders
on or about January 20, 2005.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>A shareholder
signing and returning the enclosed proxy may revoke it at any time before it is
exercised by delivering written notice to the Secretary of BASi, by filing a
properly executed proxy bearing a later date or by attending the Annual Meeting
and voting in person. The signing of a proxy does not preclude a shareholder
from attending the Annual Meeting in person. All proxies returned prior to the
Annual Meeting, and not revoked, will be voted in accordance with the
instructions contained therein. Any proxy not specifying to the contrary will be
voted (1) FOR the election of the nominees for director named below, and (2) FOR
the proposal to amend the 1997 Employee Incentive Stock Option Plan, and (3) FOR
the proposal to amend the 1997 Outside Director Stock Option Plan. Abstentions
and broker non-votes are not counted for purposes of determining whether a
proposal has been approved, but will be counted for purposes of determining
whether a quorum is present.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>As of the
close of business on December 31, 2004, the record date for the Annual Meeting,
there were outstanding and entitled to vote 4,869,502 common shares of BASi.
Each outstanding common share is entitled to one vote. BASi has no other voting
securities outstanding. Shareholders do not have cumulative voting
rights.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>A quorum will
be present if a majority of the common shares are present, in person or by
proxy, at the Annual Meeting. If a quorum is present, the nominees for director
will be elected by a plurality of the votes cast and the proposals to amend the
1997 Employee Incentive Stock Option Plan and the 1997 Outside Director Stock
Option Plan will be approved if a majority of the votes cast are votes in favor
of the proposals.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>A copy of the
BASi Annual Report and Form 10-K, including audited financial statements and a
description of operations for the fiscal year ended September 30, 2004,
accompanies this proxy statement. The financial statements contained in the
Annual Report and Form 10-K are not incorporated by reference in this proxy
statement. The solicitation of proxies is being made by BASi, and all expenses
in connection with the solicitation of proxies will be borne by BASi. BASi
expects to solicit proxies primarily by mail, but directors, officers and other
employees of BASi may also solicit proxies in person or by telephone.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A017></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>P<small>ROPOSALS FOR</small> 2006 A<small>NNUAL</small> M<small>EETING</small></B><BR>
Shareholder proposals to be considered for presentation and inclusion in the
proxy statement for the 2006 Annual Meeting of Shareholders must be submitted in
writing and received by BASi on or before September 29, 2005. If notice of any
other shareholder proposal intended to be presented at the 2006 Annual Meeting
of Shareholders is not received by BASi on or before December 13, 2005, the
proxy solicited by the Board of Directors of BASi for use in connection with
that meeting may confer authority on the proxies to vote in their discretion on
such proposal, without any discussion in the BASi proxy statement for that
meeting of either the proposal or how such proxies intend to exercise their
voting discretion. The mailing address of the principal offices of BASi is 2701
Kent Avenue, West Lafayette, Indiana 47906.</FONT></P>



<PAGE>



<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A018></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>B<small>ENEFICIAL</small> O<small>WNERSHIP OF COMMON SHARES</small></B><BR>
The following table sets forth certain data with respect to those persons known
by BASi to be the beneficial owners of five percent or more of the outstanding
common shares of BASi as of December 31, 2004, and also sets forth such data
with respect to each director of BASi, each officer listed in the Executive
Compensation table (beginning on page 6 of this proxy statement), and all
directors and executive officers of BASi as a group. Except as otherwise
indicated in the notes to the table, each beneficial owner possesses sole voting
and investment power with respect to the common shares indicated.</FONT></P>


<TABLE CELLPADDING=0 CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=85%>
<TR VALIGN=Bottom>
     <TH><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH colspan=2><FONT FACE="Arial Narrow"SIZE=2>SHARES BENEFICIALLY OWNED</FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
</TR>
<TR VALIGN=Bottom>
     <TH WIDTH=60% align=left><FONT FACE="Arial Narrow"SIZE=2>NAME<sup>(1)</sup></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH WIDTH=20%><FONT FACE="Arial Narrow"SIZE=2>NUMBER</FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH WIDTH=20%><FONT FACE="Arial Narrow"SIZE=2>PERCENT</FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peter T. Kissinger<sup>(2)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>1,290,255&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>26.5%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Ronald E. Shoup<sup>(3)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>100,739&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>2.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Candice B. Kissinger<sup>(4)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>1,290,255&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>26.5%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>William E. Baitinger<sup>(5)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>158,412&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>3.3%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Leslie B. Daniels<sup>(6)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>69,217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>1.4%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>W. Leigh Thompson<sup>(7)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>0.2%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Gayl W. Doster<sup>(8)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>2,500&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>0.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>David W. Crabb<sup>(9)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>0.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael P. Silvon<sup>(10)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>12,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>0.2%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael R. Cox<sup>(11)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>12,500&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>0.3%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Twelve executive officers and directors as a group<sup>(12)</sup></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>1,747,649&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>35.9%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<BR>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(1)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
All addresses are in care of BASi at 2701 Kent Avenue, West Lafayette, Indiana 47906.<BR>
</font></div></TD>
</TR>
</TABLE>

<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD colspan=2 WIDTH=100%><FONT FACE="Arial Narrow"SIZE=1>
Ownership includes common shares in the following denominations:</FONT></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(2)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(i)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
430,947&nbsp;&nbsp;&nbsp;shares beneficially owned by Candice B. Kissinger, Dr. Kissinger's wife
</FONT></div></TD>
</tr>
</table>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(ii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
598,504&nbsp;&nbsp;&nbsp;shares owned jointly by Dr. and Mrs. Kissinger
</FONT></div></TD>
</tr>
</table>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(iii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
8,500&nbsp;&nbsp;&nbsp;options held by Mrs. Kissinger and exercisable within 60
days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(3)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(i)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
93,517&nbsp;&nbsp;&nbsp;shares owned jointly by Dr. Shoup and his wife
</FONT></div></TD>
</tr>
</table>




<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(ii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
17,000&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>




<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(4)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(i)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
252,309&nbsp;&nbsp;&nbsp;shares beneficially owned by Dr. Kissinger
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(ii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
598,504&nbsp;&nbsp;&nbsp;shares owned jointly by Dr. and Mrs. Kissinger
</FONT></div></TD>
</tr>
</table>




<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(iii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
8,500&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(5)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(i)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
148,412&nbsp;&nbsp;&nbsp;shares owned jointly by Mr. Baitinger and his wife
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(ii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
10,000&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(6)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(i)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Excludes shares that may be acquired by Mr. Daniels upon conversion of a $100,000 convertible note, the conversion price
for which is based upon the market price of the Company's common shares for the 10 trading days prior to the date of conversion.
</FONT></div></TD>
</tr>
</table>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(ii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Includes 31,175 shares that may be acquired upon conversion of a $498,809
convertible subordinated debenture.
</FONT></div></TD>
</tr>
</table>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(7)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
10,000&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(8)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
2,500&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(9)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
5,000&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(10)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(i)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
500&nbsp;&nbsp;&nbsp;shares owned jointly by Dr. Silvon and his wife
</FONT></div></TD>
</tr>
</table>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(ii)</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
11,500&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(11)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
12,500&nbsp;&nbsp;&nbsp;options exercisable within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>



<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
(12)</FONT></TD>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>
&nbsp;</FONT></TD>
<TD WIDTH=90%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
78,000&nbsp;&nbsp;&nbsp;options exercisable by various executive officers and
directors within 60 days from December 31, 2004
</FONT></div></TD>
</tr>
</table>
<BR>
<BR>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ELECTION OF DIRECTORS</B></FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>N<small>OMINEES</small></B><BR>
The Bylaws of BASi provide for no fewer than seven and no more than nine
directors, each of whom is elected for a one-year term. The terms of all
incumbent directors will expire at the Annual Meeting. The Board of Directors
has nominated the following current directors for re-election at the Annual
Meeting. The directors nominated for election are: Peter T. Kissinger, Candice
B. Kissinger, William E. Baitinger, David W. Crabb, Leslie B. Daniels, Gayl W.
Doster and W. Leigh Thompson (collectively, the &#147;Nominated
Directors&#148;). The Board of Directors has determined that each of the
Nominated Directors other than Peter T. Kissinger and Candice B. Kissinger is an
&#147;independent director&#148; as defined in the applicable rules of the
NASDAQ Stock Market.</FONT></P>


<BR>
<BR>
<BR>

<P align=center><FONT FACE="Arial Narrow"SIZE=1>
2</FONT></P>

<PAGE>



<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
The Board of Directors recommends that shareholders vote FOR the election of all
of the Nominated Directors and, unless authority to vote for any Nominated
Director is withheld, the accompanying proxy will be voted FOR the election of
all the Nominated Directors. However, the persons designated as proxies reserve
the right to cast votes for another person designated by the Board of Directors
in the event any Nominated Director becomes unable to serve or for good cause
will not serve. Proxies will not be voted for more than seven nominees. If a
quorum is present, those nominees receiving a plurality of the votes cast will
be elected to the Board of Directors.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
The following table shows certain information about the Nominated
Directors:</FONT></P>


<TABLE CELLPADDING=0 CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=Bottom>
     <TH ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>N<small>AME</small></FONT></TH>
     <TH ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>A<small>GE</small></FONT></TH>
     <TH ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>P<small>OSITION</small></FONT></TH>
     <TH><FONT FACE="Arial Narrow"SIZE=2>S<small>ERVED AS</small><BR>D<small>IRECTOR</small> S<small>INCE</small></FONT></TH></TR>

<TR>
<TD COLSPAN=4><hr></TD></TR>

<TR VALIGN=Bottom>
     <TD WIDTH=22% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peter T. Kissinger, Ph.D.</FONT></TD>
     <TD WIDTH=13% ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>60&nbsp;</FONT></TD>
     <TD WIDTH=45% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Chairman of the Board; President; Chief Executive Officer</FONT></TD>
     <TD WIDTH=25% ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>1974</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Candice B. Kissinger</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>53&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Senior Vice President; Director of Research; Director</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>1978</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>William E. Baitinger</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>71&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Director</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>1979</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>David W. Crabb</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>51&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Director</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Leslie B. Daniels</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>57&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Director</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>2003</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Gayl W. Doster</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>66&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Director</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>W. Leigh Thompson</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>66&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Director</FONT></TD>
     <TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>1997</FONT></TD></TR>
</TABLE>




<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>B<small>USINESS</small> E<small>XPERIENCE</small> <small>OF</small>
N<small>OMINATED</small> D<small>IRECTORS</small></b><BR>
<B>Peter T. Kissinger, Ph.D.</B> founded BASi in 1974 and has served as its
Chairman, President and Chief Executive Officer since that time. He is also a
part-time Professor of Chemistry at Purdue University, where he has been
teaching since 1975. Dr. Kissinger has a Bachelor of Science degree in
Analytical Chemistry from Union College and a Ph.D. in Analytical Chemistry from
the University of North Carolina.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Candice B. Kissinger</B> has been Senior Vice President of BASi since January
2000 and currently also serves as Director of Research. She holds U.S. and
international patents for BASi products including Raturn, Culex, linear
microdialysis probe, Empis automated drug infusion system, and Chads for Vials,
with additional patents pending. Ms. Kissinger has a Bachelor of Science degree
in Microbiology from Ohio Wesleyan University and a Master of Science degree in
Food Science from the University of Massachusetts. She has served as a director
and Secretary of BASi since 1978.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>William E. Baitinger</B> has served as a director of BASi since 1979. Mr.
Baitinger was Director of Technology Transfer for the Purdue Research Foundation
from 1988 until 2000. In this capacity he was responsible for all licensing and
commercialization activities from Purdue University. He currently serves as
Special Assistant to the Vice President for Research at Purdue University. Mr.
Baitinger has a Bachelor of Science degree in Chemistry and Physics from
Marietta College and a Master of Science degree in Chemistry from Purdue
University.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>David W. Crabb, M.D.</B> has served as a director of the Company since February
2004. He has been Chairman of the Indiana University Department of Medicine
since 2001. Previously he had served as Chief Resident of Internal Medicine and
on the Medicine and Biochemistry faculty of Indiana University. He was appointed
Vice Chairman for Research for the department and later Assistant Dean for
Research. Dr. Crabb serves on several editorial boards and on the Board of
Scientific Counselors for the National Institute on Alcohol Abuse and
Alcoholism. He is a recipient of an NIH Merit award and numerous other research
and teaching awards.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Leslie B. Daniels</B> joined the BASi Board of Directors in 2003. He was a
director of PharmaKinetics Laboratories, Inc., acquired by BASi in June 2003.
Mr. Daniels is a founding partner of CAI, a private equity fund in New York
City. He previously was President of Burdge, Daniels &amp; Co., Inc., a
principal in venture capital and buyout investments as well as trading of
private placement securities, and before that, a Senior Vice President of Blyth,
Eastman, Dillon &amp; Co. where he had responsibility for the corporate fixed
income sales and trading departments. Mr. Daniels is a former Director of
Aster-Cephac SA, IVAX Corporation, MIM Corporation, Mylan Laboratories, Inc.,
NBS Technologies Inc. and MIST Inc. He was also Chairman of Zenith Laboratories,
Inc. and currently serves as Chairman of Turbo Combustor Technology Inc. and as
a Director of SafeGuard Health Enterprises, Inc.</font></p>


<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
3</FONT></P>

<PAGE>



<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Gayl W .Doster</B> has served as a director and member of the Audit Committee
of the Company since August 2004. Mr. Doster is also a director of META Group,
Inc., a publicly traded NASDAQ company. He is a CPA and was the President and
Chief Operating Officer of Sigma Micro Corporation, a computer software company
from January 1997 until his retirement in December 2002. Previously, Mr. Doster
served as Professor of Community Pharmacy Management, College of Pharmacy,
University of Rhode Island from October 1995 to January 1997. Mr. Doster
received a BS in Accounting from the Indiana University Kelley School of
Business and earned his CPA in 1965 while working for Ernst &amp;
Young.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>W. Leigh Thompson, Ph.D., M.D.</B>, has served as a director of BASi since
January 1997. Since 1995, Dr. Thompson has been Chief Executive Officer of
Profound Quality Resources, Inc., a scientific consulting firm. Prior to 1995,
Dr. Thompson was Professor of Medicine at Case Western Reserve and Indiana
Universities, President of the Society of Critical Care Medicine and Chief
Scientific Officer at Eli Lilly and Company. He earned a Bachelor of Science
degree in Biology from the College of Charleston, a Master of Science and a
Ph.D. in Pharmacology from the Medical University of South Carolina, a Medical
Doctor degree from The Johns Hopkins University and was awarded a Ph.D. of
Science from the Medical University of South Carolina. Dr. Thompson is also a
director and Chairman of the Board of Inspire Pharmaceuticals, Inc.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>S<small>CIENTIFIC</small> A<small>DVISORY</small> B<small>OARD</small></B><BR>
In 1985, BASi established a Scientific Advisory Board to assist BASi in its
research and development activities. The Scientific Advisory Board is comprised
of distinguished scientists from outside BASi who have significant
accomplishments in areas of science and technology that are important to
BASi&#146;s future. The Scientific Advisory Board interacts with BASi&#146;s
scientific and management staff. Each member of the Scientific Advisory Board is
employed outside BASi and may have commitments to, or consulting or advisory
contracts with, other entities that may conflict or compete with his or her
obligations to BASi. Generally, members of the Scientific Advisory Board are not
expected to devote a substantial portion of their time to BASi matters. Members
of the Scientific Advisory Board do not receive any compensation in connection
with attending meetings of the Scientific Advisory Board. They do, however, from
time to time, receive compensation in connection with consulting services they
render to BASi.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A023></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>F<small>AMILY</small> R<small>ELATIONSHIPS</small></B><BR>
Peter T. Kissinger and Candice B. Kissinger are husband and wife. There is no
other family relationship among the directors and executive officers of
BASi.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A024></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>C<small>OMPENSATION OF</small> D<small>IRECTORS</small></B><BR>
Directors who are not employees of BASi receive $1,500 for each Board meeting
attended, plus out-of-pocket expenses incurred in connection with attendance at
such meetings. Directors of BASi or an affiliate of BASi who are not employed by
BASi or any affiliate may also participate in the BASi 1997 Outside Director
Stock Option Plan, as may be approved from time to time by the Compensation
Committee. Options were issued to William E. Baitinger and W. Leigh Thompson in
fiscal 2003, in the amount of 9,000 shares each. Option grants of 5,000 each
were issued to David W. Crabb and Gayl W. Doster in fiscal 2004. Directors who
are employees of BASi do not receive any additional compensation for their
services as directors.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A025></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>C<small>ERTAIN</small> R<small>ELATIONSHIPS AND</small> T<small>RANSACTIONS</small></B><BR>
Leslie B. Daniels, a director of the Company currently nominated for reelection,
made various loans to PharmaKinetics Laboratories, Inc. (&#147;PKLB&#148;)
totaling $350,000 prior to the Company&#146;s acquisition of PKLB. These loans
were consolidated into a $350,000 promissory note which was convertible into
shares of common stock of PKLB (the &#147;PKLB Note&#148;). On December 31,
2003, BASi Maryland, Inc. (the former PKLB) assigned the PKLB Note to the
Company. On that same date, the Company issued a $350,000 8% convertible note
(the &#147;New Note&#148;) to Mr. Daniels in exchange for the PKLB Note, which
was cancelled. Immediately following the issuance of the New Note on December
31, 2003, the Company prepaid $100,000 of the outstanding principal amount of
the New Note, plus approximately $31,000 in accrued interest, and Mr. Daniels
converted $150,000 of the principal amount of the New Note into 38,042 Company
common shares. Following the payment and conversion, the Company issued a new 8%
convertible note due June 1, 2005, to Mr. Daniels for the remaining $100,000
principal amount.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
4</FONT></P>

<PAGE>






<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>C<small>OMMITTEES AND</small> M<small>EETINGS OF THE </small>B<small>OARD OF</small> D<small>IRECTORS</small></B><BR>
The Board of Directors has established Compensation and Incentive Stock Option,
Audit, Nominating and Executive Committees. Scheduled meetings are supplemented
by frequent informal exchange of information and actions taken by unanimous
votes without meetings.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
No member of the Board of Directors attended fewer than 75% of the meetings of
the Board of Directors and meetings of any committee of the Board of Directors
of which he or she was a member. Four out of six members of the Board of
Directors attended the 2004 Annual Meeting of shareholders. All of the members
of the Board of Directors are encouraged, but not required, to attend
BASi&#146;s annual meetings. The following chart shows the number of meetings of
each of the committees of the Board of Directors and meetings of the Board of
Directors at which a quorum was present:</FONT></P>

<TABLE CELLPADDING=0 CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=80%>
<TR VALIGN=Bottom>
     <TH align=left><FONT FACE="Arial Narrow"SIZE=2>Committee</FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH align=left><FONT FACE="Arial Narrow"SIZE=2>Members</FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH><FONT FACE="Arial Narrow"SIZE=2>Meetings in 2004</FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
<TR VALIGN=TOP>
     <TD WIDTH=45% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Compensation and Incentive Stock Option</FONT></TD>
     <TD WIDTH=35% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>William E. Baitinger<BR>
Leslie B. Daniels<BR>
Gayl W. Doster<BR>
W. Leigh Thompson</FONT></TD>
     <TD WIDTH=15% align=center><FONT FACE="Arial Narrow"SIZE=2>3&nbsp;</FONT></TD></TR>

<TR>
<TD>&nbsp;</TD></TR>


<TR VALIGN=top>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Audit</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>William E. Baitinger<BR>
Leslie B. Daniels<BR>
Gayl W. Doster<BR>
W. Leigh Thompson</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>3&nbsp;</FONT></TD></TR>


<TR>
<TD>&nbsp;</TD></TR>

<TR VALIGN=top>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Nominating</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>William E. Baitinger<BR>
David W. Crabb<BR>
Leslie B. Daniels<BR>
Gayl W. Doster<BR>
W. Leigh Thompson</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2&nbsp;</FONT></TD></TR>




<TR>
<TD>&nbsp;</TD></TR>

<TR valign=top>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Executive</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peter T. Kissinger<BR>
William E. Baitinger<BR>
W. Leigh Thompson</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>4&nbsp;</FONT></TD></TR>




<TR>
<TD>&nbsp;</TD></TR>

<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Board of Directors</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>5&nbsp;</FONT></TD></TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The
<B>Compensation and Incentive Stock Option Committee</B> makes recommendations
to the Board of Directors with respect to:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;compensation arrangements for the executive officers of BASi,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;policies relating to salaries and job descriptions,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;insurance programs,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;benefit programs, including retirement plans,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;administration of the 1990 and 1997 Employee Incentive
Stock Option Plans, and<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;the 1997 Outside Director Stock Option Plan.</FONT></P>

<P ALIGN=JUSTIFY><FONT FACE="Arial Narrow"SIZE=2>
The <B>Audit Committee</B> is responsible for:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;reviewing with the auditors the scope of the audit work performed,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;establishing audit practices,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;overseeing internal accounting controls,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;reviewing financial reporting, and<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#149;&nbsp;&nbsp;&nbsp;accounting personnel staffing.</FONT></P>


<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
5</FONT></P>

<PAGE>



<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The Board of
Directors has adopted a written charter for the Audit Committee. Audit Committee
members are not employees of BASi and, in the opinion of the Board of Directors,
are &#147;independent&#148; (as defined by Rule 4200(a)(15) of the NASD listing
standards). The Board of Directors has determined that Gayl W. Doster is an
&#147;audit committee financial expert&#148; (as defined by Item 401(h) of
Regulation S-K) and is &#147;independent&#148; (as defined by Item 7(d)(3)(iv)
of Schedule 14A).</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The
<B>Nominating Committee</B> is responsible for receiving and reviewing
recommendations for nominations to the Board of Directors and recommending
individuals as nominees for election to the Board of Directors. Nominating
Committee members are not employees of BASi and, in the opinion of the Board of
Directors, are &#147;independent&#148; (as defined by rule 4200 (a)(15) of the
NASD listing standards). The Board of Directors has not adopted a written
charter for the Nominating Committee.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The Board of
Directors will consider for nomination as directors persons recommended by
shareholders. Such recommendations must be made to the Board of Directors or to
an individual director in writing and delivered to Bioanalytical Systems, Inc.,
Attention: Corporate Secretary, 2701 Kent Avenue, West Lafayette, Indiana 47906.
The Secretary will forward all such communications to the addressee.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>There is no
fixed process for identifying and evaluating potential candidates to be nominees
for directors, and there is no fixed set of qualifications that must be
satisfied before a candidate will be considered. Rather, the Nominating
Committee has the flexibility to consider such factors as it deems appropriate.
These factors may include education, diversity, experience with business and
other organizations comparable with BASi, the interplay of the candidate&#146;s
experience with that of other members of the Board of Directors, and the extent
to which the candidate would be a desirable addition to the Board of Directors
and to any of the committees of the Board of Directors. The Nominating Committee
will evaluate nominees for directors submitted by shareholders in the same
manner in which it evaluates other director nominees. No shareholder has
properly nominated anyone for election as a director at the Annual
Meeting.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The
<B>Executive Committee</B> may exercise all of the authority of the Board of
Directors, subject to certain limitations with respect to payment of dividends,
filling of vacancies on the Board, amendment of the Articles of Incorporation or
Bylaws, approval of significant corporate transactions, issuance of shares and
other matters specified under Indiana law. The Executive Committee met four
times during fiscal 2004.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A027></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>E<small>XECUTIVE</small> C<small>OMPENSATION</small></B><BR>
The following table sets forth information with respect to the aggregate
compensation paid during each of the last three fiscal years to BASi&#146;s
President and Chief Executive Officer and each of the other executive officers
of BASi whose total compensation exceeded $100,000 during fiscal 2004 (the
&#147;Named Executive Officers&#148;).</FONT></P>


<TABLE CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=Bottom>
     <TH COLSPAN=6><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=5><FONT FACE="Arial Narrow"SIZE=2>S<small>UMMARY</small> C<small>OMPENSATION</small> T<small>ABLE</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
 </TR>
<TR VALIGN=Bottom>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>F<small>ISCAL</small> Y<small>EAR</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>S<small>ALARY</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>A<small>LL</small> O<small>THER</small><BR>
C<small>OMPENSATION</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>O<small>PTIONS</small><BR>G<small>RANTED</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>

<TR VALIGN=Bottom>
<TD WIDTH=40% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peter T. Kissinger, Ph.D.</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=5% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=6% align=center><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=5% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD>
<TD WIDTH=7% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 24,000</FONT></TD>
<TD WIDTH=3% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=12% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$27,380</FONT></TD>
<TD WIDTH=8% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(1)</sup></FONT></TD>
<TD WIDTH=2% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=7% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=2% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Chairman of the Board, President</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2003</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  30,683</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$22,829</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(1)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>and Chief Executive Officer</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2002</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 101,001</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$28,067</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(1)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>


<TR>
<TD>&nbsp;</TD></TR>


<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Ronald E. Shoup, Ph.D.</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 124,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$7,594</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(2)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>40,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Chief Operating Officer, BASi Contract</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2003</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 112,700</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$6,837</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(2)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Research Services; Director</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2002</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 113,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$7,438</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(2)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>

<TR>
<TD>&nbsp;</TD></TR>


<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Candice B. Kissinger</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 101,800</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$22,401</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(3)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>30,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Senior Vice President, Research;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2003</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  94,300</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$26,900</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(3)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Secretary and Director</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2002</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  90,700</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$27,822</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(3)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>

<TR>
<TD>&nbsp;</TD></TR>


<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael R. Cox</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  76,728</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(4)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>50,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Vice President, Finance and</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Chief Financial Officer</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>

<TR>
<TD>&nbsp;</TD></TR>


<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael P. Silvon, Ph.D.</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 106,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$ 6,784</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(5)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>30,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Vice President, Planning and</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2003</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  98,500</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$ 6,304</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(5)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Development</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD align=center><FONT FACE="Arial Narrow"SIZE=2>2002</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  94,800</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$ 7,074</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2><sup>(5)</sup></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
</TABLE>

<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
6</FONT></P>

<PAGE>






<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>(1)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Includes premiums paid on a life insurance policy on the life of Dr. Kissinger
and Mrs. Kissinger, the beneficiary of which is a trust established for their
benefit, in the amount of $20,865 in each of 2003, 2002 and 2001 and
contributions to BASi's 401(k) plan on Dr. Kissinger's behalf. </FONT></div></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>(2)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Represents contributions to BASi's 401(k) plan on Dr. Shoup's behalf. </FONT></div></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>(3)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Includes premiums paid on a life insurance policy on the lives of Mrs. Kissinger and Dr. Kissinger, the beneficiary of which is a
trust established for their benefit, in the amount of $20,865 in each of 2003, 2002 and 2001 and contributions to BASi's 401(k) plan
on Mrs. Kissinger's behalf. </FONT></div></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>(4)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Compensation is from April 1, 2004, the date Mr. Cox's employment with BASi was initiated. </FONT></div></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>(5)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Represents contributions to BASi's 401(k) plan on Dr. Silvon's behalf. </FONT></div></TD>
</TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
The following table provides information on option grants to the Named Executive
Officers in the fiscal year ended September 30, 2004:</FONT></P>

<P ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>
<B>OPTION GRANTS IN LAST FISCAL YEAR</B></FONT></P>

<TABLE CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=Bottom>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=6><FONT FACE="Arial Narrow"SIZE=2>I<small>NDIVIDUAL</small> G<small>RANTS</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TH>
     <TH COLSPAN=6><FONT FACE="Arial Narrow"SIZE=2>P<small>OTENTIAL</small> R<small>EALIZABLE</small><BR>
V<small>ALUE AT</small> A<small>SSUMED</small> A<small>NNUAL</small><BR>
R<small>ATES OF</small> S<small>TOCK</small> P<small>RICE</small><BR>
A<small>PPRECIATED FOR</small> O<small>PTION</small> T<small>ERM</small></FONT><HR WIDTH=100% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>

<TR VALIGN=Bottom>
<TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
<TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>N<small>UMBER OF</small><BR>
S<small>ECURITIES</small><BR>
U<small>NDERLYING</small><BR>
O<small>PTIONS</small><BR>
G<small>RANTED</small></FONT></TH>
<TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>% <small>OF</small> T<small>OTAL</small><BR>
O<small>PTIONS</small><BR>
G<small>RANTED TO</small><BR>
E<small>MPLOYEES IN</small><BR>
F<small>ISCAL</small> Y<small>EAR</small></FONT></TH>
<TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>E<small>XERCISE</small><BR>
P<small>RICE</small></FONT></TH>
<TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>E<small>XPIRATION</small><BR>
D<small>ATE</small></FONT></TH>
<TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>5%</FONT></TH>
<TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
<TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>10%</FONT></TH></TR>


<TR>
<TD COLSPAN=3>&nbsp;</TD>
<TD COLSPAN=18><HR>
</TD></TR>




<TR VALIGN=Bottom>

<TD WIDTH=20% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peter T. Kissinger</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=4% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=5% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>

<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=9% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=3% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=5% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=5% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD></TR>

<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Ronald E. Shoup</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>40,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>18.3%</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>     $&nbsp;&nbsp;4.511</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD COLSPAN=2 ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>2/27/2014</FONT></TD>
<TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN=right><FONT FACE="Arial Narrow"SIZE=2>$&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>113,478</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> </FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 287,575</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Candice B. Kissinger</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>30,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>13.7%</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>     $&nbsp;&nbsp;4.960</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD COLSPAN=2 ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>2/27/2009</FONT></TD>
<TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN=right><FONT FACE="Arial Narrow"SIZE=2>$&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 41,119</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> </FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  90,862</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael R. Cox</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>50,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>22.8%</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>     $&nbsp;&nbsp;4.580</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD COLSPAN=2 ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>4/01/2014</FONT></TD>
<TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN=right><FONT FACE="Arial Narrow"SIZE=2>$&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>144,017</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> </FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 364,967</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael P. Silvon</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>30,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>13.7%</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>     $&nbsp;&nbsp;4.511</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
     <TD COLSPAN=2 ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>2/27/2014</FONT></TD>
<TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN=right><FONT FACE="Arial Narrow"SIZE=2>$&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>85,108</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  </FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 215,681</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2><B>A<small>GGREGATED</small> O<small>PTION</small> E<small>XERCISES</small>
I<small>N</small> L<small>AST</small> F<small>ISCAL</small> Y<small>EAR
AND</small> F<small>ISCAL</small> Y<small>EAR-</small>E<small>ND</small>
O<small>PTION</small> V<small>ALUES</small></B><BR>
The following table sets forth certain information concerning exercisable and
unexercisable options held by the Named Executive Officers at September 30,
2004:</FONT></P>

<TABLE CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=Bottom>
     <TH COLSPAN=9><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=6><FONT FACE="Arial Narrow"SIZE=2>
N<small>UMBER OF</small> S<small>ECURITIES</small> U<small>NDERLYING</small><BR>
U<small>NEXERCISED</small> O<small>PTIONS</small> <small>AT</small><BR>
<U>S<small>EPTEMBER</small> 30, 2004</U></FONT></TH>
     <TH COLSPAN=6><FONT FACE="Arial Narrow"SIZE=2>
V<small>ALUE OF</small> U<small>NEXERCISED</small><BR>
I<small>N</small>-T<small>HE</small>-M<small>ONEY</small> O<small>PTIONS</small> <small>AT</small><BR>
<U>S<small>EPTEMBER</small> 30, 2004</U><SUP>(1)</SUP></FONT></TH></TR>
<TR   VALIGN=Bottom>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>S<small>HARES</small><BR>A<small>CQUIRED</small> <small>ON</small><BR>E<small>XERCISE</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>V<small>ALUE</small><BR>R<small>EALIZED</small> ($)</FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>E<small>XERCISABLE</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>U<small>NEXERCISABLE</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>E<small>XERCISABLE</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>U<small>NEXERCISABLE</small></FONT></TH></TR>

<TR>
<TD COLSPAN=3>&nbsp;</TD>
<TD COLSPAN=18><HR>
</TD></TR>

<TR VALIGN=Bottom>
<TD WIDTH=25% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peter T. Kissinger</FONT></TD>
<TD WIDTH=2% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=4% ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=6% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=3% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=5% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=3% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
<TD WIDTH=2% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Candice B. Kissinger</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>1,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>30,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  1,240</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 29,400</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Ronald E. Shoup</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>3,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>40,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  3,720</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 39,200</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael R. Cox</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>50,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2> 45,500</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Michael P. Silvon</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>3,500</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>500</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  6,450</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>$</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>  2,150</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
</TABLE>
<BR>


<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=1>(1)</FONT></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Arial Narrow"SIZE=1>
Calculated on the basis of $5.49 per share, which was the closing price of the
common shares as reported on the NASDAQ National Market System on September 30,
2004.</FONT></div></TD>
</TR>
</TABLE>


<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A028></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>E<small>QUITY</small> C<small>OMPENSATION</small> P<small>LAN</small>
I<small>NFORMATION</small></B><BR>
BASi maintains stock option plans that allow for the granting of options to
certain key employees and directors of BASi. The following table gives
information about equity awards under the stock option plans of BASi:</FONT></P>

<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
7</FONT></P>

<PAGE>






<TABLE CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=Bottom>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>P<small>LAN</small> C<small>ATEGORY</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>N<small>UMBER OF</small> S<small>ECURITIES</small><BR><small>TO BE</small> I<small>SSUED</small> U<small>PON</small><BR>E<small>XERCISE</small><BR><small>OF</small> O<small>UTSTANDING</small> O<small>PTIONS</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>W<small>EIGHTED</small> A<small>VERAGE</small><BR>E<small>XERCISE</small> P<small>RICE OF</small><BR>O<small>UTSTANDING</small> O<small>PTIONS</small></FONT></TH>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2>N<small>UMBER OF</small> S<small>ECURITES</small><BR>R<small>EMAINING</small> A<small>VAILABLE FOR</small><BR>F<small>UTURE</small> I<small>SSUANCE</small> U<small>NDER THE</small><BR>E<small>QUITY</small> C<small>OMPENSATION</small> P<small>LAN</small><BR>(E<small>XCLUDING</small> S<small>ECURITIES</small>)<BR>R<small>EFLECTED IN</small> F<small>IRST</small> C<small>OLUMN</small><BR></FONT></TH></TR>
<TR VALIGN=Bottom>
     <TH COLSPAN=12><FONT FACE="Arial Narrow"SIZE=2><HR></FONT></TH>
</TR>
<TR VALIGN=Bottom>

<TD WIDTH=25% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Equity compensation plans approved</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=4% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=6% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=4% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=8% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=6% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>

<TD WIDTH=4% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=12% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD WIDTH=5% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>

<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>by security holders</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>317,500</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>    $4.67</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>109,750</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Equity compensation plans not</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>approved by security holders</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>25,000</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>    $4.58</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>---</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Total</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>342,500</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>    $4.66</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2></FONT></TD>
<TD ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>109,750</FONT></TD></TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
For additional information regarding BASi&#146;s stock option plans, please see
Note 9 in the Notes to Consolidated Financial Statements in BASi&#146;s Annual
Report on Form 10-K for the fiscal year ended September 30, 2004, which is
incorporated herein by reference.
</FONT></P>





<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>R<small>EPORT OF THE</small> C<small>OMPENSATION AND</small>
I<small>NCENTIVE</small> S<small>TOCK</small> O<small>PTION</small>
C<small>OMMITTEE</small></B><BR>
William E. Baitinger, Leslie B. Daniels, Gayl W. Doster and W. Leigh Thompson
serve on the Compensation and Incentive Stock Option Committee (the
&#147;Compensation Committee&#148;). The Compensation Committee has
responsibility for the administration of BASi&#146;s executive compensation
program. None of BASi&#146;s executive officers serves as a director of, or in
any compensation-related capacity for, companies with which members of the
Compensation Committee are affiliated. The following report is submitted by the
members of the Compensation Committee:</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>BASi&#146;s
executive compensation program is designed to align executive compensation with
financial performance, business strategies and the values and objectives of
BASi. BASi&#146;s compensation philosophy is to ensure that the delivery of
compensation, both in the short and long term, is consistent with the sustained
progress, growth and profitability of BASi and acts as an inducement to attract
and retain qualified individuals. This program seeks to enhance the
profitability of BASi, and thereby enhance shareholder value, by linking the
financial interests of BASi&#146;s executives with those of its long-term
shareholders. Under the guidance of BASi&#146;s Compensation Committee, BASi has
developed and implemented an executive compensation program to achieve these
objectives while providing executives with compensation opportunities that are
competitive with companies of comparable size in related industries.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>BASi&#146;s
executive compensation program has been designed to implement the objectives
described above and is comprised of the following fundamental
elements:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=95%><DIV ALIGN=JUSTIFY><FONT FACE="Arial Narrow"SIZE=2>
&#149;&nbsp;&nbsp;&nbsp;&nbsp;A base salary that is determined by individual
contributions and sustained performance within an established competitive salary
range. Pay for performance recognizes the achievement of financial goals,
accomplishment of corporate and functional objectives, and performance of
individual business units of BASi.
</FONT></DIV></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Para Flush Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=95%><DIV ALIGN=JUSTIFY><FONT FACE="Arial Narrow"SIZE=2>
&#149;&nbsp;&nbsp;&nbsp;&nbsp;Grants of options under BASi&#146;s option plans
reward executives when shareholder value is created through increase in the
market value of BASi&#146;s common shares. Stock option grants focus executives
on managing BASi from the perspective of an owner with an equity position in the
business.
</FONT></DIV></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Base Salary.</B>&nbsp;&nbsp;&nbsp;&nbsp;The salary, and any periodic increase
thereof, of the President and Chief Executive Officer were and are determined by
the Board of Directors of BASi based on recommendations made by the Compensation
Committee, excluding Dr. Kissinger. The salaries, and any periodic increases
thereof, of all other executive officers are determined by the Board of
Directors based on Committee recommendations.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>BASi, in
establishing base salaries, levels of incidental and/or supplemental
compensation, and incentive compensation programs for its officers and key
executives, assesses periodic compensation surveys and published data covering
both the BASi industry and other industries. The level of base salary
compensation for officers and key executives is determined by both the scope of
their responsibility and the salary ranges for officers and key executives of
BASi established by the Board of Directors and the Compensation Committee.
Periodic increases in base salary are dependent on the executive&#146;s
proficiency of performance in the individual&#146;s position for a given period
and on the executive&#146;s competency, skill and experience.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
8</FONT></P>

<PAGE>




<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
On his own initiative the fiscal 2003 compensation level for the President and
Chief Executive Officer was significantly reduced and redistributed to select
BASi staff. Dr. Kissinger&#146;s annual base salary was returned to its previous
level of $101,001 on October 1, 2004. Base salary increases for other eligible
BASi staff were distributed in the first fiscal quarter of 2005.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Bonus.</B>&nbsp;&nbsp;&nbsp;&nbsp;In years in which the after-tax net income
of BASi exceeds an increase of 7% over the previous year&#146;s after-tax net
income, the Compensation Committee is authorized to award bonuses to any BASi
employee at the Committee&#146;s discretion.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Option Plans.</B>&nbsp;&nbsp;&nbsp;&nbsp;Granting of options pursuant to
BASi&#146;s option plans is intended to align executive interest with the
long-term interests of shareholders by linking executive compensation with
enhancement of shareholder value. In addition, grants of options motivate
executives to improve long-term stock market performance by allowing them to
develop and maintain a significant long-term equity ownership position in
BASi&#146;s common shares. In fiscal 2004 options to purchase 234,000 shares
were awarded to executives and employees at an average exercise price of $4.52
per share.</FONT></P>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=40%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=60%><FONT FACE="Arial Narrow"SIZE=2>
Respectfully submitted,<BR>
William E. Baitinger, Leslie B. Daniels, Gayl W. Doster and W. Leigh Thompson</font></TD>
</TR>
</TABLE>
<BR>
<BR>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A030></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>A<small>UDIT</small> C<small>OMMITTEE</small> R<small>EPORT</small></B><BR>
The Audit Committee reviews BASi&#146;s financial reporting process on behalf of
the Board of Directors. In fulfilling its responsibilities, the Audit Committee
has reviewed the audited financial statements contained in the Annual Report on
Form 10-K for the fiscal year ended September 30, 2004 with BASi&#146;s
management and the independent registered public accountants. These reviews
included quality, not just acceptability, of accounting principles,
reasonableness of significant judgments, and clarity of disclosures in financial
statements. Management is responsible for the financial statements and the
reporting process, including administering the systems of internal control. The
independent registered public accountants are responsible for expressing an
opinion on the conformity of those audited financial statements with accounting
principles generally accepted in the United States.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The Audit Committee
discussed with the independent registered public accountants, the matters
required to be discussed by Statement on Auditing Standards No. 61,
Communication with Audit Committees, as amended. In addition, the Audit
Committee has discussed with the independent registered public accountants their
independence from BASi and its management, including the matters in the written
disclosures required by Independence Standards Board Standard No. 1,
Independence Discussions with Audit Committees, as amended, and considered the
compatibility of non-audit services with the auditors&#146;
independence.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>In reliance on the
reviews and discussions referred to above, the Audit Committee recommended to
the Board of Directors that the audited financial statements be included in
BASi&#146;s Annual Report on Form 10-K for the fiscal year ended September 30,
2004 for filing with the SEC, and the Board has so approved the audited
financial statements.</FONT></P>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=40%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=60%><FONT FACE="Arial Narrow"SIZE=2>
Respectfully submitted,<BR>
William E. Baitinger, Leslie B. Daniels, Gayl W. Doster and W. Leigh Thompson</font></TD>
</TR>
</TABLE>
<BR>
<BR>


<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A031></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>S<small>TOCK</small> P<small>RICE</small> P<small>ERFORMANCE</small> G<small>RAPH</small></B><BR>
The line graph below compares yearly percentage change in the cumulative total
stockholder return on BASi&#146;s common shares against the cumulative total
return on the NASDAQ Composite Index and a composite index based on a group of
ten publicly traded contract research and chemical instrumentation organizations
(the &#147;Peer Group Index&#148;) for the period commencing September 30, 1998
and ending September 30, 2004.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
9</FONT></P>

<PAGE>




<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
The Peer Group Index is comprised of: AAIpharma, Inc.; Covalent Group, Inc.;
Kendle International, Inc.; New Brunswick Scientific Co., Inc.; Molecular
Devices; Pharmaceutical Product Development, Inc.; OI Corp.; Covance, Inc.; Gene
Logic, Inc.; and Bio-Rad, Inc. The comparison of total return on investment
(change in year-end stock price plus reinvested dividends) for the applicable
period assumes that $100 was invested on September 30, 1998 in each of BASi, the
NASDAQ Composite Index and the Peer Group Index.</FONT></P>


<P ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>
<B>C<small>OMPARISON OF</small> C<small>UMULATIVE</small> T<small>OTAL</small> R<small>ETURN</small><BR>
A<small>MONG</small> B<small>IOANALYTICAL</small> S<small>YSTEMS</small>, I<small>NC., THE</small> N<small>ASDAQ</small><BR>
C<small>OMPOSITE</small> I<small>NDEX AND THE</small> P<small>EER</small> G<small>ROUP</small> I<small>NDEX</small></B></FONT></P>


<P ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>
<IMG SRC="graph.gif"></FONT></P>


<TABLE CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=Bottom>
     <TH COLSPAN=3><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>1999</FONT></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>2000</FONT></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>2001</FONT></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>2002</FONT></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>2003</FONT></TH>
     <TH COLSPAN=1><FONT FACE="Arial Narrow"SIZE=2></FONT></TH>
     <TH COLSPAN=2><FONT FACE="Arial Narrow"SIZE=2>2004</FONT></TH></TR>
<TR VALIGN=Bottom>
     <TH COLSPAN=21><FONT FACE="Arial Narrow"SIZE=2><HR></FONT></TH></TR>
<TR VALIGN=Bottom>
     <TD WIDTH=50% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Bioanalytical Systems, Inc.</FONT></TD>
     <TD WIDTH=1% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=3% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>100</FONT></TD>
        <TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>88</FONT></TD>
        <TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>191</FONT></TD>
        <TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>101</FONT></TD>
        <TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>140</FONT></TD>
        <TD WIDTH=4% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD WIDTH=1% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD WIDTH=3% ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>179</FONT></TD>
        <TD WIDTH=2% ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Nasdaq Composite Index</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>100</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>134</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>55</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>43</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>65</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>69</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>Peer Index</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>100</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>163</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>158</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>127</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>149</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD>
     <TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD><TD ALIGN=RIGHT><FONT FACE="Arial Narrow"SIZE=2>171</FONT></TD>
        <TD ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>&nbsp;</FONT></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A032></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>S<small>ECTION</small> 16(A) B<small>ENEFICIAL</small> O<small>WNERSHIP</small> R<small>EPORTING</small> C<small>OMPLIANCE</small></B><BR>
Section 16(a) of the Securities Exchange Act of 1934 requires the BASi directors
and executive officers and persons who own more than ten percent of a registered
class of the BASi equity securities to file with the SEC initial reports of
ownership and reports of changes in ownership of common shares and other equity
securities of BASi. Officers, directors and greater-than-ten-percent
shareholders are required by SEC regulation to furnish BASi with copies of all
Section 16(a) reports they file. Except as set forth below and based solely upon
the review of Section 16(a) reports furnished to BASi during or with respect to
fiscal 2004 and written representations by the BASi officers, directors and
greater-than-ten-percent beneficial owners that no other reports were required,
BASi is not aware of any instance of noncompliance or late compliance with
Section 16(a) during or with respect to fiscal 2004.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
Mr. Silvon was late in filing a Form 3.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A033></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>C<small>OMMUNICATIONS</small> W<small>ITH THE</small> B<small>OARD OF</small> D<small>IRECTORS</small></B><BR>
Currently, BASi shareholders may send communications for the Board of Directors
directly to Peter T. Kissinger, Chairman of the Board of Directors, under the
&#147;Ask Pete&#148; portion of the BASi website found at
<I>www.bioanalytical.com</I>. The Board of Directors is also in the process of
implementing a shareholder communication policy in order to better facilitate
communications between shareholders and all members of the Board of
Directors.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A034></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>S<small>ELECTION OF</small> I<small>NDEPENDENT</small> A<small>CCOUNTANTS</small></B><BR>
On July 14, 2004, the Company&#146;s Audit Committee of the Board of Directors
approved the dismissal of the Company&#146;s independent public accountants,
Ernst &amp; Young LLP (&#147;E&amp;Y&#148;) and the engagement of KPMG LLP
(&#147;KPMG&#146;) for the audit of financial statements for the year ending
September 30, 2004.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The reports
of E&amp;Y for the past two fiscal years ended September 30, 2003 and 2002
contained no adverse opinion or disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope, or accounting principles. In connection
with its audits for the two most recent fiscal years ended September 30, 2003
and 2002, and through July 14, 2004, there have been no disagreements with
E&amp;Y on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which disagreements, if not resolved
to the satisfaction of E&amp;Y, would have caused them to make reference to the
subject matter of the disagreement in connection with their report on the
financial statements for such period.</FONT></P>


<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
10</FONT></P>

<PAGE>



<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>During the
two most recent fiscal years ended September 30, 2003 and 2002, and through July
14, 2004, there have been no reportable events (as defined in Regulation S-K,
Item 304(a)(1)(v)), except for a material weakness in the Company&#146;s
internal control for the year ended September 30, 2003 which was identified by
E&amp;Y and disclosed in Item 9A in the Company&#146;s Annual Report on Form
10-K for the year ended September 30, 2003. Specifically, the independent
registered public accountants noted that the Company&#146;s internal control
failed to timely alert management of potential loan covenant noncompliance. The
Company did not have procedures in place to monitor near-term future financial
position and results of operations to enable it to take operational action in
the event of potential loan covenant noncompliance. The Company has taken
measures to correct this material weakness in the form of enhancing its planning
process and creating procedures to more timely identify credit agreement
compliance issues. E&amp;Y discussed this issue with the Audit Committee of the
Board of Directors, and has been authorized by the Company to respond fully to
the inquiries of KPMG.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>E&amp;Y has
furnished the Company with a letter addressed to the Securities and Exchange
Commission (the &#147;Commission&#148;) stating that they agree with the above
statements. A copy of the E&amp;Y letter dated August 5, 2004 was filed as
Exhibit 16.1 to the Company&#146;s Amendment No. 1 to Form 8-K dated July 14,
2004.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>Prior to the
engagement of KPMG, management of BASi had not consulted with KPMG on any
matters. Representatives of KPMG are expected to be present at the Annual
Meeting. They will have the opportunity to make a statement if they desire to do
so and will be available to respond to appropriate questions concerning the
audit of BASi&#146;s financial statements.</FONT></P>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
<B>A<small>UDIT</small> F<small>EES</small></B></FONT></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;2004</font></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;2003</font></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
Aggregate fees for annual audit, quarterly reviews<sUP>(1)</sUP></FONT></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
$202,462</font></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
$316,015</font></TD>
</TR>
</TABLE>
<BR>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
<B>T<small>AX</small> F<small>EES</small></B></FONT></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;2004</font></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;2003</font></TD>
</TR>
</TABLE>
<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
Income tax services related to compliance with tax laws</FONT></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
$108,298</font></TD>
<TD WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
$&nbsp;&nbsp;64,920</font></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(1)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=JUSTIFY><FONT FACE="Arial Narrow"SIZE=2>
Audit fees paid in fiscal 2004 include $51,000 paid to KPMG for the third
quarter review and work on fiscal 2004 audit; all other tax and audit fees
presented were paid to Ernst &amp; Young.</FONT></DIV></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>BASi&#146;s policies
require that the scope and cost of all work to be performed for BASi by its independent
registered public accountants must be approved by the Audit Committee. Prior to the
commencement of any work by the independent registered public accountants on behalf of
BASi, the independent registered public accountants provide an engagement letter describing
the scope of the work to be performed and an estimate of the fees. The Audit Committee and
the Chief Financial Officer must review and approve the engagement letter and the estimate
before authorizing the engagement. Where fees charged by the independent registered public
accountants exceed the estimate, the Audit Committee must review and approve the excess
fees prior to their payment.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;APPROVAL OF AMENDMENT TO THE 1997 EMPLOYEE INCENTIVE STOCK OPTION PLAN<BR>
</B><BR>
On October 23, 1997, the Board of Directors of BASi adopted the Employee
Incentive Stock Option Plan (the &#147;Employee Option Plan&#148;), which was
subsequently approved by the shareholders of BASi prior to the initial public
offering. In 2003, the shareholders of BASi approved an amendment to the
Employee Option Plan increasing the number of BASi common shares available for
grant under the Employee Option Plan to a total of 395,000. On January 14, 2005,
the BASi Board of Directors approved an amendment to the Employee Option Plan,
described below in further detail, to amend the Employee Option Plan to increase
the number of BASi common shares available for grant under the Employee Option
Plan by 250,000 shares (for a total of 645,000 shares available for grant),
subject to approval by the shareholders of BASi.
</FONT></P>

<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
11</FONT></P>

<PAGE>





<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The principal
features of the Employee Option Plan, including an explanation of the material
change contemplated by the proposed amendment, are described below, but such
description is qualified entirely by reference to the text of the Employee
Option Plan, a copy of which is attached to this Proxy Statement as Appendix A.
Except as otherwise described below in the explanation of the proposed
amendment, all other existing provisions of the Employee Option Plan are not
changed.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A035></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>P<small>ROPOSED</small> P<small>LAN</small> A<small>MENDMENT</small>;
I<small>NCREASE IN</small> A<small>UTHORIZED</small>
S<small>HARES</small></B><BR>
As of December 31, 2004, no common shares remained available for additional
option grants under the Employee Option Plan. The Board of Directors amended the
Employee Option Plan, subject to shareholder approval, to increase the number of
shares available for issuance under the Employee Option Plan. Because of
historic grant patterns and expansion plans for the Company, the Board of
Directors believe the number of shares presently available for grant and those
which may become available in the future will not give BASi sufficient
flexibility to structure future incentives. Therefore, if shareholders approve
the proposed amendment, an additional 250,000 shares would become available for
grants under the Employee Option Plan.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A036></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>S<small>UMMARY OF THE</small> E<small>MPLOYEE</small> O<small>PTION</small> P<small>LAN</small></B><BR>
<B>General.</B>&nbsp;&nbsp;&nbsp;&nbsp;The purpose of the Employee Option Plan
is to further the growth, development and financial success of BASi by providing
additional incentives to certain eligible employees and permitting those persons
to benefit directly from the growth, development and financial success of
BASi.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Administration.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Employee Option Plan is
administered by an Incentive Stock Option Committee consisting of three (3) or
more members of the Board of Directors of BASi (the &#147;Employee
Committee&#148;). The Employee Committee has the authority to interpret and
construe the provisions of the Employee Option Plan or any option granted under
it, determine exercise periods, and prescribe, amend and rescind rules and
regulations with regard to the Employee Option Plan.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Eligibility.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options under the Employee
Option Plan may be granted only to those persons who are employees of BASi and
who are eligible to participate. Eligibility shall be determined by the Employee
Committee from time to time; provided that no option shall be granted to any
employee of BASi who, at the time such option is granted, owns shares (together
with such person&#146;s brothers, sisters, spouse, ancestors and lineal
descendants) possessing more than ten percent (10%) of the total combined voting
power of all classes of shares of BASi or any parent or subsidiary of BASi (a
&#147;10% Shareholder&#148;). The percentage limitations do not apply if at the
time such option is granted the option price is at least one hundred ten percent
(110%) of the fair market value of the shares subject to the option and such
option is not exercisable after the expiration of five (5) years from the date
such option is granted.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Maximum Number of Shares.</B>&nbsp;&nbsp;&nbsp;&nbsp;As amended by the Board
of Directors of BASi, subject to approval by the shareholders of BASi, the
aggregate number of shares for which options may be granted under the Employee
Option Plan is 645,000, subject to adjustments for recapitalizations. Any shares
subject to an option that expires or is terminated shall again become available
for grant. Prior to the amendment by the Board of Directors of BASi, the
aggregate number of shares for which options could be granted under the Employee
Option Plan was 395,000, subject to adjustments for
recapitalizations.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Maximum Exercise Rule.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Employee Option Plan
limits the aggregate fair market value (determined at the time the option is
granted) of the shares with respect to which incentive stock options are
exercisable for the first time during any calendar year to $100,000.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Exercise Price.</B>&nbsp;&nbsp;&nbsp;&nbsp;Any grant of options under the
Employee Option Plan shall have an exercise price of not less than the fair
market value per share of the shares on the date of granting of the option. The
exercise price of an option granted under the Employee Option Plan may be paid
(i) in cash, (ii) by certified check or bank cashier&#146;s check, (iii) through
the tender to BASi of shares of BASi or through the withholding of shares of
BASi that are subject to the option, or (iv) by a combination of the foregoing;
provided that the Employee Committee may impose limitations on the use of shares
to exercise options. Any grant of options under the Employee Option Plan to a
10% Shareholder must be in an amount per share not less than one hundred ten
percent (110%) of the fair market value per share of the shares on the date of
the granting of the option.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
12</FONT></P>

<PAGE>



<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Term of Options and Time of Exercise.</B>&nbsp;&nbsp;&nbsp;&nbsp;No term of
any option granted under the Employee Option Plan shall be in excess of ten (10)
years; provided, however, if the person to whom the option is granted is a 10%
Shareholder, the term shall not be longer than five (5) years.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Termination of Employment.</B>&nbsp;&nbsp;&nbsp;&nbsp;Upon cessation of
employment with BASi or certain entities affiliated with BASi, all options
granted under the Employee Option Plan held by such employee shall terminate as
to any unexercised portion thereof; provided, however, that if the cessation of
employment is due to retirement with the consent of BASi such employee may
exercise any such options within three (3) months after such cessation and if
the cessation of employment is due to permanent or total disability or death
such employee or such employee&#146;s personal representative, as the case may
be, may exercise any such options within 12 months after such cessation of
employment.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Merger, Dissolution or Liquidation.</B>&nbsp;&nbsp;&nbsp;&nbsp;Upon merger or
consolidation, BASi may terminate any option outstanding on 30 days written
notice. Upon dissolution or liquidation of BASi, BASi shall provide 30 days
written notice to all holders of options and each unexercised option shall
terminate upon dissolution or liquidation.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Assignability.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options may not be assigned or
transferred, except by will or by the laws of descent and distribution, and
during an optionee&#146;s lifetime may be exercised only by the
optionee.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Term of the Employee Option Plan.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Employee
Option Plan may be terminated by the Board of Directors of BASi at any time with
respect to shares as to which options have not been granted. No options may be
granted under the plan after its termination.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Amendment.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of BASi may
amend, suspend or discontinue the Employee Option Plan with respect to any
shares as to which options have not been granted. The approval of the holders of
a majority of the outstanding shares of each class of voting shares of BASi is
required for any amendment to the Employee Option Plan relating to (i) an
increase in the number of shares for which options may be granted, (ii) a change
in the class of shares for which options may be granted, and (iii) a change in
the manner in which the option price is determined.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Withholdings.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Employee Committee has the right
to require persons receiving options to remit to BASi amounts sufficient to
satisfy any federal, state or local income tax withholding
requirements.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A037></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>F<small>EDERAL</small> I<small>NCOME</small> T<small>AX</small> C<small>ONSEQUENCES</small></B><BR>
The federal income tax consequences of an employee&#146;s participation in the
Employee Option Plan are complex and subject to change. The following discussion
is only a summary of the general rules applicable to stock options granted under
the Employee Option Plan as of the date hereof. The application of state and
local income taxes and other federal taxes is not discussed. For individuals
resident outside the United States, the tax consequences to the individual and
to BASi are determined by the applicable tax laws of the foreign
jurisdiction.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The grant of
an incentive stock option under the Employee Option Plan generally will have no
federal income tax consequences for BASi or the optionee. Except for alternative
minimum tax purposes, the exercise of an incentive stock option pursuant to the
Employee Option Plan will have no federal income tax consequences to BASi or the
optionee. An optionee generally will recognize capital gain or loss upon the
sale of shares acquired in exercising an incentive stock option, provided that
the shares are sold at least two years after the date of grant of the option and
at least one year after the optionee acquires the shares. An optionee generally
will recognize ordinary income upon the sale of shares acquired in exercising an
incentive stock option if the sale is made within two years of the date the
option was granted or within one year of the date the shares were transferred to
the optionee. In such event, the amount of ordinary income recognized by the
optionee generally will equal the difference between the option price and the
fair market value of the shares on the date of exercise. BASi may take an income
tax deduction for compensation conveyed by an incentive stock option only in
situations (and the taxable year) in which the employee must recognize ordinary
income.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
13</FONT></P>

<PAGE>



<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>Furthermore, if the
compensation attributable to awards is not &#147;performance-based&#148; within the
meaning of Section 162(m) of the Internal Revenue Code, BASi may not be permitted to
deduct the aggregate non performance-based compensation in excess of $1,000,000 in certain
circumstances.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A038></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>N<small>EW</small> P<small>LAN</small> B<small>ENEFITS</small></B><BR>
BASi currently anticipates that it will, as a general matter, grant options on
an annual basis. However, future option grant recipients, and future option
grant levels, have not been determined. Therefore, the number, amount and type
of awards to be received by or allocated to eligible persons in the future under
the Employee Option Plan cannot be determined at this time. BASi has not
approved any awards under the Employee Option Plan that are conditioned upon
shareholder approval of the proposed plan amendment. On January 10, 2005 the
closing price of a common share of BASi was $5.10.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A039></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>V<small>OTE</small> R<small>EQUIRED</small></B><BR>
The approval of the amendment to the Employee Option Plan requires the
affirmative vote of the holders of a majority of the outstanding common
shares.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The Board of
Directors of BASi recommends a vote FOR the approval of the amendment to the
Employee Option Plan.</FONT></P>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;APPROVAL OF AMENDMENT TO THE 1997 OUTSIDE DIRECTOR STOCK OPTION PLAN<BR>
</B><BR>
On October 23, 1997, the Board of Directors of BASi adopted the 1997 Outside
Director Stock Option Plan (&#147;Director Option Plan&#148;). In 2003, the
shareholders of BASi approved an amendment to the Director Option Plan
increasing the number of BASi common shares available for grant under the
Director Option Plan to a total of 30,000. On January 14, 2005, the BASi Board
of Directors approved an amendment to the Director Option Plan, described below
in further detail, to amend the Director Option Plan to increase the number of
BASi common shares available for grant under the Director Option Plan by 25,000
shares (for a total of 55,000 shares available for grant), subject to approval
by the shareholders of BASi.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The principal
features of the Director Option Plan, as amended, are described below, but such
description is qualified entirely by reference to the text of the Director
Option Plan, a copy of which is attached to this Proxy Statement as Appendix
B.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A040></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>P<small>ROPOSED</small> P<small>LAN</small> A<small>MENDMENT</small>;
I<small>NCREASE IN </small>A<small>UTHORIZED</small> S<small>HARES</small></B><BR>
As of December 31, 2004, no common shares remained available for additional
option grants under the Director Option Plan. The Board of Directors amended the
Director Option Plan, subject to shareholder approval, to increase the number of
shares available for issuance under the Director Option Plan. Because of
historic grant patterns and expansion plans for the Company, the Board of
Directors believe the number of shares presently available for grant and those
which may become available in the future will not give BASi sufficient
flexibility to structure future incentives. Therefore, if shareholders approve
the proposed amendment, an additional 30,000 shares would become available for
grants under the Director Option Plan.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A041></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>S<small>UMMARY OF THE</small> D<small>IRECTOR </small>O<small>PTION</small> P<small>LAN</small></B><BR>
<B>Purpose.</B>&nbsp;&nbsp;&nbsp;&nbsp;The purpose of the Director Option Plan
is to be an incentive to, and to encourage ownership of the shares of BASi by,
outside directors in order to provide such outside directors with a direct and
proprietary interest in the welfare and success of BASi and to encourage
continuity on the Board of Directors.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Administration.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Director Option Plan is
administered by the Director Option Committee consisting of three (3) or more
members of the Board of Directors of BASi (the &#147;Director Committee&#148;).
The Director Committee has authority to interpret and construe the provisions of
the Director Option Plan or any option granted under it, to select outside
directors to whom grants of options shall be made, to prescribe, amend and
rescind rules and regulations relative to the Director Option Plan, to determine
the terms and conditions of each option granted and to make any other
determinations regarding the Director Option Plan not addressed
therein.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
14</FONT></P>

<PAGE>


<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Eligibility.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options under the Director
Option Plan may be granted only to persons who are outside directors of BASi.
Eligibility shall be determined by the Director Committee from time to
time.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Maximum Number of Shares.</B>&nbsp;&nbsp;&nbsp;&nbsp;As amended by the Board
of Directors of BASi, the aggregate number of shares for which options may be
granted under the Director Option Plan is 30,000, subject to adjustments for
recapitalizations. Any shares subject to an option that expires or is terminated
shall again become available for grant. Prior to the amendment by the Board of
Directors of BASi, the aggregate number of shares for which options could be
granted under the Director Option Plan was 5,000, subject to adjustments for
recapitalizations.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Exercise Price.</B>&nbsp;&nbsp;&nbsp;&nbsp;Any grant of options under the
Director Option Plan shall have an exercise price of not less than the fair
market value per share of the shares on the date of granting of the option. The
exercise price of an option granted under the Director Option Plan may be paid
(i) in cash, (ii) by certified check or bank cashier&#146;s check, (iii) through
the tender to BASi of shares of BASi or through the withholding of shares of
BASi that are subject to the option, or (iv) by a combination of the foregoing;
provided that the Director Committee may impose limitations on the use of shares
to exercise options.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Term of Options and Time of Exercise.</B>&nbsp;&nbsp;&nbsp;&nbsp;No term of
any option granted under the Director Option Plan shall be in excess of ten (10)
years. Each option granted under the Director Option Plan shall be exercisable
in four (4) equal installments. The option may be exercised as to the shares
covered by the first installment from and after the second anniversary of the
grant of the option, with second, third and fourth installments becoming
exercisable on the three (3) succeeding anniversary dates; provided that any
such limitation on the exercise of an option may be rescinded, modified or
waived by the Director Committee.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Termination of Service as a Director.</B>&nbsp;&nbsp;&nbsp;&nbsp;In the event
an individual ceases to serve as a director of BASi or of any one of certain
entities affiliated with BASi, all options granted under the Director Option
Plan held by such individual shall terminate as to any unexercised portion
thereof; provided that if the cessation of service is due to retirement with the
consent of BASi such individual may exercise any such options within three (3)
months after such cessation and if the cessation of service is due to permanent
or total disability or death such individual or such individual&#146;s personal
representative, as the case may be, may exercise any such options within 12
months after such cessation of service.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Adjustments upon Merger or Dissolution.</B>&nbsp;&nbsp;&nbsp;&nbsp;Upon
merger or consolidation, BASi may terminate any option outstanding on 30 days
written notice. Upon dissolution or liquidation of BASi, BASi shall provide 30
days written notice to all holders of options and each unexercised option shall
terminate upon dissolution or liquidation.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Assignability.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options may not be assigned or
transferred except by will or by the laws of descent and distribution and during
an optionee&#146;s lifetime may be exercised only by the optionee.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Term of the Director Option Plan.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options may be
granted under the Director Option Plan until the ten (10) year anniversary of
the adoption of the Director Option Plan.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Project" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Amendment.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of BASi may
amend, suspend or discontinue the Director Option Plan with respect to any
shares as to which options have not been granted. The approval of the holders of
the options under the Director Option Plan is required for any amendment to the
Director Option Plan that would alter any of the rights or obligations of BASi
or any holder of options with respect to the outstanding option.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Withholdings.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Director Committee has the right
to require persons receiving options to remit to BASi amounts sufficient to
satisfy any federal, state or local income tax withholding
requirements.</FONT></P>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
15</FONT></P>

<PAGE>




<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A042></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>F<small>EDERAL</small> I<small>NCOME</small> T<small>AX</small> C<small>ONSEQUENCES</small></B><BR>
The holder of an option will not be subject to tax at the time a nonqualified
option is granted; however, a director who exercises a nonqualified option must
include in income as of the date of exercise the difference between (i) the
amount paid for the shares upon exercise of the option and (ii) the fair market
value of the shares. The recognized income may be subject to withholding for
federal, state and local income and other payroll taxes. The optionee&#146;s
federal income tax cost basis for the shares will be the amount paid for the
shares plus the income recognized. If an optionee uses shares in full or partial
payment of the exercise price of a nonqualified option, the exchange should not
affect the federal income tax treatment of the exercise. The optionee will
realize no gain or loss with respect to the shares so used. The net additional
shares received upon such exercise by the optionee will have a federal income
tax cost basis equal to the ordinary income recognized as a result of the option
exercise (plus the amount of any cash used in the option exercise) and a holding
period commencing upon the date such income is recognized. Subsequent sale of
such shares will result in a capital gain or loss equal to the difference
between the optionee&#146;s federal income tax cost basis for the shares and the
sale price.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Workstation" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>BASi will be entitled
to a federal income tax deduction in the amount of the ordinary income recognized by the
optionee as of the date the optionee recognizes ordinary income.</FONT></P>

<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A043></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>N<small>EW</small> P<small>LAN</small> B<small>ENEFITS</small></B><BR>
The following table sets forth certain information regarding the benefits
expected to be received by persons in each indicated group under the Director
Option Plan, as amended. The 30,000 shares previously authorized by the Director
Option Plan were available for grants only to non-executive directors of BASi.
As of December 31, 2004, options to purchase 28,000 of such shares had been
granted, and 2,000 remained available for grant. On January 10, 2005 the closing
price of a common share of BASi was $5.10.</FONT></P>


<P ALIGN=CENTER><FONT FACE="Arial Narrow"SIZE=2>
<B>N<small>EW</small> P<small>LAN</small>
B<small>ENEFITS</small>:&nbsp;&nbsp;1997 B<small>IOANALYTICAL</small>
S<small>YSTEMS</small>, I<small>NC.</small><BR> O<small>UTSIDE</small>
D<small>IRECTOR</small> S<small>TOCK</small> O<small>PTION</small>
P<small>LAN</small></B></FONT></P>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
<B>N<small>AME AND</small> P<small>OSITION</small></B></FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
<B>D<small>OLLAR</small> V<small>ALUE</small> ($)</B></FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
<B>N<small>UMBER OF</small> U<small>NITS</small></B></FONT></TD></TR>

<TR>
<TD COLSPAN=3><HR></TD></TR>

<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
CEO</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD></TR>


<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
Executive Group</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD></TR>


<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
Non-Executive Director Group</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
25,000</FONT></TD></TR>


<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Arial Narrow"SIZE=2>
Non-Executive Officer Employee Group </FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD>
<TD ALIGN=CENTER WIDTH=25%><FONT FACE="Arial Narrow"SIZE=2>
0</FONT></TD></TR>
</TABLE>
<BR>





<!-- MARKER FORMAT-SHEET="ARTICLE -TNR" FSL="Project" -->
<A NAME=A044></A>
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>V<small>OTE</small> R<small>EQUIRED</small></B><BR>
The approval of the Director Option Plan requires that the votes cast for
approval of the Director Option Plan by the shareholders of BASi exceed those
cast against approval of the Director Option Plan by the shareholders of
BASi.</FONT></P>

<!-- MARKER FORMAT-SHEET="BASi Flush Para" FSL="Default" -->
<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>The Board of
Directors of BASi recommends a vote FOR the approval of the Director Option
Plan.</FONT></P>


<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
16</FONT></P>

<PAGE>




<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OTHER MATTERS</B><BR>
<BR>
As of the date of this proxy statement, the Board of Directors of BASi has no
knowledge of any matters to be presented for consideration at the Annual Meeting
other than those referred to above. If (a) any matters not within the knowledge
of the Board of Directors as of the date of this proxy statement should properly
come before the meeting; (b) a person not named herein is nominated at the
meeting for election as a director because a nominee named herein is unable to
serve or for good cause will not serve; (c) any proposals properly omitted from
this proxy statement and the form of proxy should come before the meeting; or
(d) any matters should arise incident to the conduct of the meeting, then the
proxies will be voted in accordance with the recommendations of the Board of
Directors of BASi.</FONT></P>

<!-- MARKER FORMAT-SHEET="Signature Block" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Arial Narrow"SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=40%><FONT FACE="Arial Narrow"SIZE=2>
By Order of the Board of Directors,<BR>

<IMG SRC="candicesign.gif"><BR>

Candice B. Kissinger<BR>
Secretary<BR>
January 17, 2005<BR>
</font></TD>
</TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>APPENDIX A</B></FONT></P>

<P ALIGN=CENTER><FONT FACE="Arial Narrow Bold" SIZE="3">
<B>B<small>IOANALYTICAL</small> S<small>YSTEMS</small>, I<small>NC</small>.<BR>
1997 E<small>MPLOYEE</small> I<small>NCENTIVE</small> S<small>TOCK</small> O<small>PTION</small> P<small>LAN</small><BR>
<small>(AS AMENDED JANUARY 14, 2005)</small></B></FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Purpose.</B>&nbsp;&nbsp;&nbsp;&nbsp;This
1997 Employee Incentive Stock Option Plan (hereinafter referred to as the
&#147;Plan&#148;) is intended to be an incentive to, and to encourage share
ownership by, key employees of Bioanalytical Systems, Inc. and its subsidiaries
(hereinafter collectively referred to as the &#147;Employer&#148;) in the manner
contemplated by Section 422 of the Internal Revenue Code of 1986, as amended
(&#147;Code&#148;), in order to provide such employees with a more direct and
proprietary interest in the welfare and success of the Employer and to insure
their continuation as employees of the Employer.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Administration.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
Plan shall be administered by an Incentive Stock Option Committee (hereinafter
referred to as the &#147;Committee&#148;) consisting of three (3) or more
members of the Board of Directors of Bioanalytical Systems, Inc. (the
&#147;Company&#148;) who are appointed from time to time by the Board of
Directors of the Company. The Board of Directors of the Company may from time to
time remove members from, or add members to, the Committee. Vacancies on the
Committee, howsoever caused, shall be filled by the Board of Directors of the
Company. The Committee shall have the power to interpret and construe the
provisions of the Plan or any option granted under it, and such interpretation
or construction shall be final and binding. The Committee may prescribe, amend
and rescind rules and regulations relative to the Plan or its construction or
interpretation. A majority of the Committee shall constitute a quorum. All
determinations of the Committee shall be made by not less than a majority of its
members. No member of the Committee shall be liable for any action or
determination made in good faith.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligibility.</B>&nbsp;&nbsp;&nbsp;&nbsp;Only
those persons who are employees of the Employer shall be eligible to participate
in the Plan. The Committee shall determine from time to time the particular
employees of the Employer who shall be eligible to participate in the Plan and
the extent of their participation therein. No option shall be granted under the
Plan to any employee of the Employer who, at the time such option is granted,
owns shares possessing more than ten percent (10%) of the total combined voting
power of all classes of shares of the Company or of any parent or subsidiary
corporation of the Company or any parent or subsidiary corporation of any of the
foregoing (such employee being hereinafter referred to as a &#147;10%
Shareholder&#148;), except as provided below. In determining whether the
percentage limitations of this paragraph are met, an employee shall be
considered as owning any shares owned, directly or indirectly, by or for his
brothers or sisters (whether by the whole or half blood), spouse, ancestors, and
lineal descendants. For purposes of this paragraph 3, shares owned, directly or
indirectly, by or for a corporation, partnership, estate, or trust shall be
considered as being owned proportionately by or for its shareholders, partners,
or beneficiaries. The percentage limitations of this paragraph 3 shall not
apply, however, if at the time such option is granted the option price is at
least one hundred ten percent (110%) of the fair market value of the shares
subject to the option and such option by its terms is not exercisable after the
expiration of five (5)years from the date such option is
granted.</FONT></P>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
shares subject to the options and other provisions of the Plan shall be shares
of the Company&#146;s authorized, but unissued, or reacquired Common Shares (the
&#147;Common Shares&#148;). The total amount of the Common Shares on which
options may be granted shall not exceed in the aggregate Six Hundred Forty-Five
Thousand (645,000) shares, except as such number of shares shall be adjusted in
accordance with the provisions set forth in paragraph 6(g) hereof. In the event
any outstanding option under the Plan expires or is terminated for any reason
prior to the end of the period during which options may be granted, the Common
Shares allocable to the unexercised portion of such option may again be subject
to an option under the Plan. During the period that any options granted
hereunder are outstanding, the Employer shall reserve and keep available such
number of Common Shares as will be sufficient to satisfy all outstanding,
unexercised options.</FONT></P>


<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
17</FONT></P>

<PAGE>








<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Maximum Exercise
Rule.</B>&nbsp;&nbsp;&nbsp;&nbsp;The aggregate fair market value (determined at
the time the option is granted) of the shares with respect to which incentive
stock options are exercisable for the first time by an employee during any
calendar year under all such plans of the Employer and any parent or subsidiary
corporation of the Employer shall not exceed One Hundred Thousand Dollars
($100,000.00).<BR>
<BR>
6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Terms and Conditions of
Options.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options granted pursuant to the Plan shall
be evidenced by agreements in such form as the Committee shall from time to time
prescribe, which agreements shall comply with and be subject to the following
terms and conditions:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(a)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Medium and Time of Payment.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option price shall
be payable in United States dollars upon the exercise of the option and shall be
paid (i) in cash; (ii) by certified check or by bank cashier&#146;s check; (iii)
through the tender to the Company of Common Shares of the Company or through the
withholding of Common Shares of the Company that are subject to the option,
which Common Shares shall be valued, for purposes of determining the extent to
which the purchase price has been paid, at their fair market value on the date
of exercise as determined in Section 6(c); or (iv) by a combination of the
methods described in (i), (ii), or (iii); provided, however, that the Committee
may in its discretion impose and set forth in the option agreement pertaining to
an option such limitations or prohibitions on the use of Common Shares to
exercise options as it deems appropriate. Fair market value of the Common Shares
shall be determined by the Committee in the same manner that it is determined in
establishing option prices. Payment of the option price shall be accompanied by
a written subscription agreement in a form to be prescribed by the Committee.
</FONT></div></TD></TR>
</TABLE>


<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(b)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Number of Shares.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option agreement shall state
the total number of shares to which it pertains, and the date of the grant of
the option. The Committee may prescribe in the option agreement a minimum number
of Common Shares with respect to which an option may be exercised, in whole or
in part.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(c)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Option Price.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option price shall be an amount
per share not less than the fair market value per share of the Common Shares on
the date of granting of the option. In the case of options granted to an
employee of the Employer who is a 10% Shareholder, the option price shall be an
amount per share not less than one hundred ten percent (110%) of the fair market
value per share of the Common Shares on the date of the granting of the option.
Fair market value shall mean, if the price of the Common Shares is so reported,
the closing price for the Common Shares on the National Association of
Securities Dealers Automated Quotation System or any exchange on which the
Common Shares are then traded, as reported in The Wall Street Journal (Midwest
Edition). If the price of Common Shares is not so reported, fair market value
shall be determined, in good faith, by the Committee in accordance with such
procedures as the Committee shall from time to time prescribe.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(d)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Term of Options.</B>&nbsp;&nbsp;&nbsp;&nbsp;The term of each option granted
under the Plan shall expire within the period prescribed in the agreement
relating thereto, which shall not be more than five (5) years from the date the
option is granted if the optionee is a 10% Shareholder and not more than ten
(10) years from the date the option is granted if the optionee is not a 10%
Shareholder.</FONT></div></TD></TR>
</TABLE>


<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(e)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Date of Exercise.</B>&nbsp;&nbsp;&nbsp;&nbsp;Each option shall be exercisable
as determined by the Committee and set forth in an option agreement, provided,
however, that any such limitation on the exercise of an option contained in an
option agreement may be rescinded, modified, or waived by the Committee, in its
sole discretion, at any time and from time to time after the date of grant of
such option so as to accelerate the time in which the option may be exercised.
Except as specifically restricted by the Committee, any option may be exercised
in whole at any time or in part from time to time during its
term.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(f)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Termination of Employment.</B>&nbsp;&nbsp;&nbsp;&nbsp;In the event an
optionee shall cease to be employed by the Employer, a parent corporation of the
Employer, or a corporation or a parent or a subsidiary corporation of such
corporation issuing or assuming an option in a transaction to which Section
424(g) of the Code applies, all options outstanding in the hands of the optionee
shall terminate immediately as to any unexercised portion thereof; provided,
however, that if any cessation of employment is due to retirement with the
consent of the Employer or permanent and total disability, the optionee shall
have the right, subject to the provisions of paragraph 6(d) and paragraph 6(e)
hereof, to exercise the option, with respect to the shares for which it could
have been exercised on the effective date of his cessation of employment, at any
time within three (3) months after such cessation of employment due to
retirement with the consent of the Employer or at any time within twelve (12)
months after such cessation of employment due to permanent and total disability;
and provided further, that if the employee shall die while in the employ of the
Employer, the employee&#146;s personal representative shall have the right,
subject to the provisions of paragraph 6(d) and paragraph 6(e) hereof, to
exercise the option with respect to the shares for which it could have been
exercised on the date of death, at any time within twelve (12) months from the
date of death. Whether a cessation of employment is to be considered a
retirement with the consent of the Employer or due to permanent and total
disability, and whether an authorized leave of absence or absence on military or
government service shall be deemed to constitute termination of employment, for
the purposes of the Plan, shall be determined by the Committee, which
determination shall be final and conclusive.</FONT></div></TD></TR>
</TABLE>


<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
18</FONT></P>

<PAGE>



<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(g)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Recapitalization.</B>&nbsp;&nbsp;&nbsp;&nbsp;The aggregate number of Common
Shares on which options may be granted hereunder, the number of shares thereof
covered by each outstanding option, and the price per share thereof in each such
option, shall all be proportionately adjusted for any increase or decrease in
the number of issued Common Shares resulting from a subdivision or consolidation
of shares or any other capital adjustment, the payment of a share dividend, or
other increase or decrease in the Common Shares effected without receipt of
consideration by the Employer. In the event that, prior to the delivery by the
Employer of the Common Shares remaining under any outstanding option hereunder,
there shall be a capital reorganization or reclassification of the capital of
the Employer resulting in a substitution of other shares for the Common Shares,
there shall be substituted the number of substitute shares which would have been
issued in exchange for the Common Shares then remaining under the option if such
Common Shares had been then issued and outstanding.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(h)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Merger, Dissolution.</B>&nbsp;&nbsp;&nbsp;&nbsp;If the Employer shall be a
party to any merger or consolidation, the Employer shall have the right to
terminate any option outstanding on thirty (30) days written notice; provided,
however, if such merger or consolidation is not consummated within 180 days from
the date of the aforementioned notice, all options terminated shall be deemed to
have been continuously in effect since the date of execution thereof. In the
event of a dissolution or liquidation of the Employer, the Employer shall give
each optionee thirty (30) days written notice thereof; every unexercised option
outstanding hereunder shall be deemed to be terminated upon such dissolution or
liquidation.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(i)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Assignability.</B>&nbsp;&nbsp;&nbsp;&nbsp;No option shall be assignable or
transferable except by will or under the laws of descent and distribution.
During the lifetime of an optionee, the option shall be exercisable only by the
optionee.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(j)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Issuance of Shares and Compliance with Securities
Laws.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Employer may postpone the issuance and
delivery of certificates representing shares until (a) the admission of such
shares to listing on any stock exchange on which shares of the Employer of the
same class are then listed and (b) the completion of such registration or other
qualification of such shares under any state or federal law, rule or regulation
as the Employer shall determine to be necessary or advisable, which registration
or other qualification the Employer shall use its best efforts to complete;
provided, however, a person purchasing shares pursuant to the Plan has no right
to require the Employer to register the Common Shares under federal or state
securities laws at any time. Any person purchasing shares pursuant to the Plan
may be required to make such representations and furnish such information as
may, in the opinion of counsel for the Employer, be appropriate to permit the
Employer, in light of the existence or non-existence with respect to such shares
of an effective registration under the Securities Act of 1933, as amended, or
any similar state statute, to issue the shares in compliance with the provisions
of those or any comparable acts.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(k)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Rights as a Shareholder.</B>&nbsp;&nbsp;&nbsp;&nbsp;An optionee shall have no
rights as a shareholder with respect to shares covered by an option until the
date of issuance of a certificate to him and only after such shares are fully
paid. No adjustment will be made for dividends or other rights for which the
record date is prior to the date such certificate is issued.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Arial Narrow"SIZE=2>
(l)</FONT></TD>
<TD WIDTH=90%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Other Provisions.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option agreements entered
into under the Plan shall contain such other provisions as the committee shall
deem advisable.</FONT></div></TD></TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Term of
Plan.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall become effective upon the
approval by the holders of a majority of the issued and outstanding shares of
each class of the voting shares of the Company voting in person or by proxy at a
duly held shareholders&#146; meeting; provided, however, that the Plan shall
become effective only if approved by such shareholders within twelve (12) months
before or after the date the Plan is adopted by the Company Board of Directors.
The Board of Directors may, in its sole discretion, terminate the Plan at any
time with respect to any shares as to which options have not been granted. No
option shall be granted under the Plan thereafter.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Amendment of the
Plan.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of the Company may from
time to time, alter, amend, suspend, or discontinue the Plan with respect to any
shares as to which options have not been granted; provided, however, that the
Board of Directors may not, without further approval by the holders of a
majority of the issued and outstanding shares of each class of voting shares of
the Company:<BR>

(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;increase the maximum number
of shares as to which options may be granted under the Plan (other than to
reflect a stock split or stock dividend);<BR>

(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;change the class of shares
for which options may be granted under the Plan; or<BR>

(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;change the provisions of
paragraph 6(c) concerning the option price.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Application of
Funds.</B>&nbsp;&nbsp;&nbsp;&nbsp;The proceeds received by the Company from the
sale of shares pursuant to options granted hereunder will be used for general
corporate purposes.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>No Obligation to Exercise
Option.</B>&nbsp;&nbsp;&nbsp;&nbsp;The granting of an option hereunder shall
impose no obligation upon the optionee to exercise such an
option.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Continuance of
Employment.</B>&nbsp;&nbsp;&nbsp;&nbsp;Neither the adoption of the Plan nor the
granting of an option hereunder shall impose any obligation on the Employer to
continue the employment of an optionee.</FONT></P>


<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
19</FONT></P>

<PAGE>



<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Applicability of
Amendments.</B>&nbsp;&nbsp;&nbsp;&nbsp;All outstanding options shall be deemed
to be amended so as to include, to the extent applicable thereto, any amendments
made to the Plan subsequent to the granting of such options.</FONT></P>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Withholdings.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
Committee shall have the right to require optionees to remit to the Company
amounts sufficient to satisfy any federal, state or local income tax withholding
requirements (or make other arrangements satisfactory to the Company with regard
to such taxes) at such times as the Company deems necessary or appropriate for
compliance with such laws.</FONT></P>

<!-- MARKER FORMAT-SHEET="Head Major Left Bold-TNR" FSL="Default" -->
<A NAME=A045></A>
<H1 ALIGN=LEFT><FONT FACE="Arial Narrow"SIZE=2>
APPENDIX B</FONT></H1>

<P ALIGN=center><FONT FACE="Arial Narrow"SIZE=3>
<B>1997 BIOANALYTICAL SYSTEMS, INC.<BR>
OUTSIDE DIRECTOR STOCK OPTION PLAN</b><BR>
<small>(AS AMENDED JANUARY 14, 2005)</small></FONT></P>
<BR>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Definitions.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
following terms shall have the meanings hereinafter set forth:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(a)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Affiliate&#148; means a corporation which is a parent or subsidiary
corporation of the Company, or a corporation or a parent or a subsidiary
corporation of the Company issuing or assuming the options issued under the Plan
in a transaction in which Section 424(g) of the Code applies.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(b)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Board of Directors&#148; means the board of directors of the Company, as
it shall exist from time to time.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(c)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Code&#148; means the Internal Revenue Code of 1986, as it shall be amended
from time to time.</FONT></div></TD></TR>
</TABLE>


<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(d)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Committee&#148; means the director stock option committee administering
the Plan as provided in paragraph 3 hereof.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(e)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Common Shares&#148; means the Common Shares of the
Company.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(f)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Company&#148; means Bioanalytical Systems, Inc., an Indiana corporation.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(g)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Nonstatutory Stock Option&#148; means an option which is not an incentive
stock option within the meaning of Section 422 of the Code and which is governed
by Section 83 of the Code for Federal income tax purposes.</FONT></div></TD></TR>
</TABLE>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(h)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Optionee&#148; means an Outside Director granted an option under the Plan.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(i)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Outside Director&#148; means any director of the Company or an Affiliate
who is not employed by the Company or any Affiliate in any capacity.</FONT></div></TD></TR>
</TABLE>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(j)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
&#147;Plan&#148; means this 1997 Bioanalytical Systems, Inc. Outside Director
Stock Option Plan.</FONT></div></TD></TR>
</TABLE>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Purpose.</B>&nbsp;&nbsp;&nbsp;&nbsp;This
Plan is intended to be an incentive to, and to encourage ownership of the Common
Shares by, Outside Directors of the Company and its Affiliates in order to
provide such Outside Directors with a more direct and proprietary interest in
the welfare and success of the Company and to encourage their continuation as
directors of the Company. The Plan is further intended to promote continuity of
membership on the Board of Directors and to increase the incentive to promote
the welfare of the Company by those who are primarily responsible for shaping
and carrying out the long-term plans and objectives of the Company, thereby
furthering and securing the Company&#146;s continued growth and financial
success. It is contemplated that only Nonstatutory Stock Options will be granted
under the Plan.</FONT></P>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Administration.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
Plan shall be administered by the Committee which shall consist of three or more
members of the Board of Directors who are appointed from time to time by the
Board of Directors. The Board of Directors may from time to time remove members
from, or add members to, the Committee. Vacancies on the Committee, howsoever
caused, shall be filled by the Board of Directors. The Committee shall have the
power (a) to interpret and construe the provisions of the Plan or any option
granted under it, and such interpretation or construction shall be final and
binding; (b) to select Outside Directors to whom grants of options under the
Plan shall be made as more particularly set forth in paragraph 4 hereof; (c) to
determine the terms and conditions of each option granted hereunder; (d) to
determine the time at which such grants shall be made and the number of Common
Shares to be optioned under such grant; and (e) to make any other determinations
regarding the Plan which are not otherwise expressly provided herein. The
Committee may prescribe, amend and rescind rules and regulations relative to the
Plan or its construction or interpretation. A majority of the Committee shall
constitute a quorum. All determinations of the Committee shall be made by the
vote of a majority of its members; provided, however, that if there are fewer
than three (3) members of the Committee at any time, all determinations shall be
a joint determination of its members. No member of the Committee shall be liable
for any action or determination made in good faith.<BR>
<BR>
4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligibility.</B>&nbsp;&nbsp;&nbsp;&nbsp;Only
those persons who are Outside Directors shall be eligible to participate in the
Plan. The Committee shall determine from time to time the particular Outside
Directors who shall be eligible to participate in the Plan and the extent of
their participation therein.</FONT></P>




<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
20</FONT></P>

<PAGE>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
shares subject to the options and other provisions of the Plan shall be the
Company&#146;s authorized, but unissued, or reacquired Common Shares. The total
number of the Common Shares on which options may be granted under the Plan shall
not exceed in the aggregate fifty-five thousand (55,000) shares, except as such
number of shares shall be adjusted in accordance with the provisions set forth
in paragraph 6(g) hereof. In the event any outstanding option under the Plan
expires or is terminated for any reason prior to the end of the period during
which options may be granted, the Common Shares allocable to the unexercised
portion of such option may again be subject to an option under the Plan. During
the period that any options granted hereunder are outstanding, the Company shall
reserve and keep available such number of Common Shares as will be sufficient to
satisfy all outstanding, unexercised options.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Terms and Conditions of
Options.</B>&nbsp;&nbsp;&nbsp;&nbsp;Options granted pursuant to the Plan shall
be evidenced by agreements in such form as the Committee shall from time to time
prescribe, which agreements shall comply with and be subject to the following
terms and conditions:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(a)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Medium and Time of Payment.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option price shall
be payable in United States dollars upon the exercise of the option and shall be
paid (i) in cash; (ii) by certified check or by bank cashier&#146;s check; (iii)
through the tender to the Company of Common Shares of the Company or through the
withholding of Common Shares of the Company that are subject to the option,
which Common Shares shall be valued, for purposes of determining the extent to
which the purchase price has been paid, at their fair market value on the date
of exercise as determined in Section 6(c); or (iv) or by a combination of (i),
(ii) or (iii); provided, however, that the Committee may in its discretion
impose and set forth in the option agreement pertaining to an option such
limitations or prohibitions on the use of Common Shares to exercise options as
it deems appropriate. Fair market value of any Common Shares surrendered or
withheld shall be determined by the Committee in the same manner that it is
determined in establishing option prices. Payment of the option price shall be
accompanied by a written subscription agreement in a form to be prescribed by
the Committee.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(b)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Number of Shares, Date of Grant.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option
agreement shall state the total number of shares to which it pertains, and the
date of the grant of the option. The Committee may prescribe in the option
agreement a minimum number of Common Shares with respect to which an option may
be exercised, in whole or in part.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(c)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Option Price.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option price shall be an amount
per share not less than the fair market value per share of the Common Shares on
the date of grant of the option. Fair market value shall mean, if the price is
so reported, the closing price for the Common Shares on the National Association
of Securities Dealers Automated Quotation System or any exchange on which the
Common Shares are then traded, as reported in The Wall Street Journal (Midwest
Edition). If the price of Common Shares is not so reported, fair market value
shall be determined, in good faith, by the Committee in accordance with such
procedures as the Committee shall from time to time prescribe.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(d)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Term of Options.</B>&nbsp;&nbsp;&nbsp;&nbsp;Each option granted under the
Plan shall expire within the period prescribed in the agreement relating
thereto, which shall not be more than ten (10) years from the date the option is
granted.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(e)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Time of Exercise.</B>&nbsp;&nbsp;&nbsp;&nbsp;Each option granted pursuant
to the Plan shall be exercisable in four equal installments. The option may be
exercised as to the shares covered by the first installment from and after the
second anniversary of the grant of the option, with second, third and fourth
installments becoming exercisable on the three succeeding anniversary dates;
provided, however, that any such limitation on the exercise of an option
contained in an option agreement may be rescinded, modified or waived by the
Committee, in its sole discretion, at any time and from time to time after the
date of grant of such option so as to accelerate the time in which the option
may be exercised. Except as specifically restricted by the provisions of this
paragraph 6(e) or by the Committee acting hereunder, any option may be exercised
in whole at any time or in part from time to time during its term.</FONT></div></TD></TR>
</TABLE>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(f)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Cessation of Service as a Director.</B>&nbsp;&nbsp;&nbsp;&nbsp;In the event
an Optionee ceases to serve as a director of the Company or an Affiliate all
options outstanding in the hands of the Optionee shall terminate immediately as
to any unexercised portion thereof; provided, however, that if any cessation of
service is due to retirement with the consent of the Company or is due to
permanent and total disability, the Optionee shall have the right, subject to
the provisions of paragraphs 6(d) and 6(e) hereof, to exercise the option, with
respect to the Common Shares for which it could have been exercised on the
effective date of the Optionee&#146;s cessation of service, at any time within
three (3) months after such cessation of service due to retirement with the
consent of the Company or at any time within twelve (12) months after such
cessation of service due to permanent and total disability; and provided
further, that if the Optionee shall die while serving as a director of the
Company or an affiliate, the Optionee&#146;s personal representative shall have
the right, subject to the provisions of paragraphs 6(d) and 6(e) hereof, to
exercise the option with respect to the Common Shares for which the option could
have been exercised on the date of death, at any time within twelve (12) months
from the date of the Optionee&#146;s death. Whether a cessation of service is a
retirement with the consent of the Company or due to permanent and total
disability, and whether an authorized leave of absence or absence on military or
government service shall be deemed to constitute cessation of service for the
purposes of the Plan, shall be determined by the Committee in its sole
discretion, which determination shall be final and
conclusive.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(g)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Recapitalization.</B>&nbsp;&nbsp;&nbsp;&nbsp;The aggregate number of Common
Shares on which options may be granted hereunder, the number of Common Shares
covered by each outstanding option, and the price per share set forth in each
option agreement, shall all be proportionately adjusted for any increase or
decrease in the number of issued Common Shares resulting from a subdivision or
consolidation of shares of the Company or any other capital adjustment of the
Company, the payment of a share dividend, a share split or any other increase or
decrease in the Common Shares effected without receipt of consideration by the
Company. In the event that, prior to the delivery by the Company of the Common
Shares remaining unexercised under any outstanding option hereunder, there shall
be a capital reorganization or reclassification of the capital of the Company
resulting in a substitution of other shares for the Common Shares, there shall
be substituted the number of substitute shares which would have been issued in
exchange for the Common Shares then remaining under the option if such Common
Shares had been then issued and outstanding.</FONT></div></TD></TR>
</TABLE>



<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow"SIZE=1>
21</FONT></P>

<PAGE>




<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(h)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Merger, Dissolution.</B>&nbsp;&nbsp;&nbsp;&nbsp;If the Company shall be a
party to any merger or consolidation, the Company shall have the right to
terminate any option outstanding on thirty (30) days&#146; written notice;
provided, however, if such merger or consolidation is not consummated within 180
days from the date of the aforementioned notice, all options terminated shall be
deemed to have been continuously in effect since the date of execution thereof.
In the event of a dissolution or liquidation of the Company, the Company shall
give each optionee thirty (30) days written notice specifying the effective date
thereof. Every unexercised option outstanding hereunder on the date set by the
Company as the effective date of the dissolution or liquidation shall be deemed
to be terminated upon such dissolution or liquidation.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(i)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Nonassignability.</B>&nbsp;&nbsp;&nbsp;&nbsp;No option granted under the Plan
shall be assignable or transferable except by will or under the laws of descent
and distribution. During the lifetime of an Optionee, the option shall be
exercisable only by the Optionee.</FONT></div></TD></TR>
</TABLE>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(j)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Issuance of Shares and Compliance with Securities
Laws.</B>&nbsp;&nbsp;&nbsp;&nbsp;the Company may postpone the issuance and
delivery of certificates representing Common Shares until (a) the admission of
such shares to listing on any stock exchange on which shares of the Company of
the same class are then listed and (b) the completion of such registration or
other qualification of such shares under any state or Federal law, rule or
regulation or the rules and regulations of any exchange upon which the Common
Shares are treated as the Company shall determine to be necessary or advisable,
which registration or other qualification the Company shall use its best efforts
to complete; provided, however, a person purchasing Common Shares pursuant to
the Plan has no right to require the Company to register the Common Shares under
federal or state securities laws at any time. Any person purchasing Common
Shares pursuant to the Plan may be required to make such representations and
furnish such information as may, in the opinion of counsel for the Company, be
appropriate to permit the Company, in light of the existence or non-existence
with respect to such shares of an effective registration under the Securities
Act of 1933, as amended, or any similar state statute, to issue the shares in
compliance with the provisions of those or any comparable acts.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(k)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Rights as a Shareholder.</B>&nbsp;&nbsp;&nbsp;&nbsp;An Optionee shall have no
rights as a shareholder with respect to Common Shares covered by an option until
the date of issuance of a certificate to the Optionee. The certificate shall not
be issued until the Optionee has exercised the option and has fully paid for the
Common Shares acquired thereby. No adjustment will be made for dividends or
other rights for which the record date is prior to the date such certificate is
issued.</FONT></div></TD></TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para (List) Flush Lv 0- TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Arial Narrow"SIZE=2>
(l)</FONT></TD>
<TD WIDTH=95%><DIV ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
<B>Other Provisions.</B>&nbsp;&nbsp;&nbsp;&nbsp;The option agreements entered
into under the Plan shall contain such other provisions, limitations,
restrictions and requirements as the Committee shall deem
advisable.</FONT></div></TD></TR>
</TABLE>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Term of the
Plan.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall become effective upon the date
the Plan is adopted by the Board of Directors. The Plan shall terminate ten (10)
years after the date the Plan is adopted by the Board of Directors, or on such
earlier date as the Board of Directors may determine. No option shall be granted
under the Plan after such termination date.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Amendment of the
Plan.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors may from time to time,
alter, amend, suspend, or discontinue the Plan with respect to any Common Shares
as to which options have not been granted; provided, however, that no action may
be taken hereunder which would alter or impair any of the rights or obligations
of the Company or any Optionee with respect to any outstanding option without
the consent of the Optionee thereof.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Application of
Funds.</B>&nbsp;&nbsp;&nbsp;&nbsp;The proceeds received by the Company from the
sale of Common Shares pursuant to options granted hereunder will be used for
general corporate purposes.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>No Obligation to Exercise
Option.</B>&nbsp;&nbsp;&nbsp;&nbsp;The granting of an option hereunder shall
impose no obligation upon the Optionee to exercise such an
option.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>No Right to
Reelection.</B>&nbsp;&nbsp;&nbsp;&nbsp;Neither the adoption of the Plan, the
granting of an option hereunder, nor any other action taken relating to the Plan
shall impose any obligation on the Company or any Affiliate or the Board of
Directors of either to nominate any Outside Director for reelection as a
director by the shareholders of the Company or any Affiliate.</FONT></P>

<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Applicability of
Amendments.</B>&nbsp;&nbsp;&nbsp;&nbsp;All outstanding options shall be deemed
to be amended so as to include, to the extent applicable thereto, any amendments
made to the Plan subsequent to the granting of such options.</FONT></P>


<P ALIGN=justify><FONT FACE="Arial Narrow"SIZE=2>
13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Withholdings.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
Committee shall have the right to require the Optionee to remit to the Company
amounts sufficient to satisfy any applicable withholding requirements set forth
in the Code or under state or local law relating to options granted to the
Optionee. The Company shall have the right, to the extent permitted by law, to
deduct from any payment of any kind otherwise due to an Optionee who exercises
an option any federal, state or local taxes of any kind required by law to be
withheld with respect to the Common Shares subject to such option.</FONT></P>


<BR>
<BR>
<BR>
<P align=center><FONT FACE="Arial Narrow" SIZE="1">
22</FONT></P>



</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>basilogo.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 basilogo.gif
M1TE&.#EA:@`B`-4``````/___Z"@I/_[\/CX^/'Q\>KJZN/CX]W=W=?7U\S,
MS,O+R\#`P+*RLIF9F9:6EH:&AH"`@'=W=V9F9E]?7U5554U-34)"0CDY.3,S
M,RDI*2(B(AP<'!86%A$1$0P,#`@("`0$!/___P``````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````"'Y!`$``"(`+`````!J`"(```;_
MP(!P2"P:C\AA0>#H:)X:SJ21K%JOV$"E0N%RNV#PUVMA9`V34(>SV4"C'5#$
M@%58Q!3\%H\W%A@"#0(,"4,<AXB)BHL<(!B%51,=3AIN;VYN'1X050H<'AN,
MHHL;10L-J*FH0F^MKJ]M(4D&'QV83Y:P:T@*(96OP*YN1`F!JJH!4&V7N<O*
MEAP71P9KN)?!4:5&M\_,W=U*Q^('V.5O(`I%M-;FE[9%"1^Y[;`:0PCBXO38
M&Q[I1!DH[7O6H0*1"AP&`ALFA$&^8PJ!^2/RP$-$5Q^H")F0\.*U(0X?IO+8
M"AT17_,N;N@P1!))9?8:BASI\98'!$.:I/3H02."_P\OK0TY,!/52S<<#`[!
ML-,C!PI#VC3=QU!(40,DD<H:8H!-4%Q5#8#P6C.F$*(/S8Q:BRA$!3H@0["=
MFZA#")Q"#&`82Y?1+B(*!(D3$J&PX<.($TLX8`2!A,20(T.6`%?)8\F8'Q])
M()@!XRR@0XL>33I)@M.H4ZM>K0`2D0*M5\N>S?IS@MBT:?\S8J"W[]^]/WCX
M0%QX<>/#BR?O`-1,7`_0C2L_GISX\.K&0TQ@)3PZ]N_'/_B*H*YH@Z`;0"@-
ML,#B5R@<)`AAFM6N\P`&S'_ET$%^``;NO1>%?QAT5!]7^GW5CQ#M"?A$?/--
M1=53>26X'R<`.CC@?`;6M/]!"'3D5]0W8)%8R3S#,&!+*\Z<Z$V)OT`80($L
MHMA,2FY\4(B(,PF87@`*!/B>C/0%=8A\!A@CDH^R9.@@D1V2U,$#^%F8513;
MJ:@AD1)2!4(!58[XG@=F:/DD@5&J%!./2^Z'`8-"'K7AC%V:DXE&G(W(S9Z_
MP)1+(Y`L`((U?%I2Z#7]"7%!1X<:VB=2&H1@`4CF'1+*I9>R8:FFG&IBP6?_
MA9"IIJ&0RD:FI8[*WW8!9&#JJZ.J"IU&8<Z$P!865)"K!;OJBJNNO5X``5Y#
M*'#!K[SZZNNNO>:ZK+/";N1LLM-2B^P6%S`P`!'F-4!L:>"&*VX`!>03$C+C
DIJL?+A8%Y%F4`(QU*^^\]-9KKTCP6G7OOOSV:Z\"!`P1!``[
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>candicesign.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 candicesign.gif
M1TE&.#EA@0`R`,0``````/___Z"@I/CX^/'Q\>KJZN/CX]W=W=?7U\S,S,#`
MP+*RLIF9F9:6EH:&AH"`@'=W=V9F9E]?7U5554U-34)"0CDY.3,S,RDI*2(B
M(AP<'!86%@P,#`0$!/___P```"'Y!`$``!X`+`````"!`#(```7_8"".9&F>
M:*JN;.N^L&M,7:;$>*[OO!EI"H+APN@9CTB>85,D:9+0J+3$R)P>@NGIINVR
M(A&4`.(=12[EM.FR2$&:7D6'H*X'+@C54ZIIBP@=!W9J&08K'5$&'1$8(QT-
M@VF%*PYD20F(%@XB%VB17AMYAU`*'"*(`9B?7A5<*A"61ZH!%F$!'8:K4Q-P
M*8!)!:@'J!H3NE,.MBL;!4ESIX(4>R,/RB@)@L<I"IXK$;T]'7X2$@$,J"0%
MTR<=$ZW:)P;K*0\/+J(J8"(,&P$('<TVD?"#`IT)!6TFN++3CT4E%PZL>/N#
M*E"`":9>Y#+Q0%P'BX,D$$RQP)J*83#Z_]R"1"-`LP`.LDA8)&*:`T@!*'3@
M0D/!A@HFTQRPP$)`T!0=LD`D^@#-A9VW`E3XV('!A$T1.FS8H"%#OZHN:77`
M-"O`2%`O4S2PYP*"1`445OQ"B8&F@VING_P+,(R"`T09!%!0&H!#U3E^`W2L
MH,;HBGHO]IYJ)B'NB0QMJFKXD2HI!0JF_AFJH4B!!,8<%B0`-,Q3!<-021P0
M<+>'@H4&3U#PD]5"@@!T2!!H%OM`W,\H%J`QO$%.9],2^D'`!;,?DXM_E#\K
ML:`#FP<4+FRP,+-#.8T*(E#(T$'#!64-8ID8\K+8+0W!+#QK0+7<!H$.-&)9
M"8A<\!`SW0G0P?]T^P2744%IE:!`)0XD4(`#&FB`4PH&+/"`!'5I58L`^)"0
MVT`#2A#&,`-\=$X`$5BADUFH[.6="7=-8,LP4VF%$@P=L,7A7Q4(%(`!!B2P
MP`)K1?<1!A1$T,!O+"#030D0&.D`4?\L4)>4%BQ@!0T(`"(0(G^Q0],(%"C@
MEF(+L:!?"@@P0D&)!\#5WGL.+(!`A#"(=,([(B3PQ%\42&#!5\'D5`%J'>11
M@9\=&&FBD">`LT)W<:8209$O*7G3`@IDD\2#(R"`080:1/0`5VD6J6)J$>AG
MZH+B`#K%1[*1T\"2#33`@&K!34$`JHH158(`%1CPEP(/_-:'3WG`%:'_AW7H
MU$P#^@4)@0`*;)2&/",LL>$)&&`*CX0?:<#!5;H.@@@![L2[+@H$*,"`!.Y^
M1.6]WG'0:0D%G+M*G@QDJ6@&$A@PG:7KJLC"`5?:44`"\36`D`,23+!`+L$@
MNZYD;BA;QP$>?J-``75^4Z((-)AZKP@90#S"`AP0%@?'?8HRQ@-G$6CSS!D8
M4ZX#&QQ%2C(0$$2;BB^CH.G,(GAIF`:3=J'O-Z:B##758-.9<(7!&6!5!*N%
MK38)9H]:;,L.1+WVS+-EN7*JR3@P\-SK%C!ATQL54)*4Q?)-]0$.)"YS>A$\
M(+?AVA1`V[<D)`#>!#I#?J\!`CS`@+C[3M"`2KB:PY-OXD&((+AZ#^Q=^BH%
M,.#RS3I&D/GKVF#<`&%&D3,T[KHL($'K(C0P@01Z%PX\/!!4H'$E1@6]_+H=
..<*"B`,I/K_WVNH0``#L_
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>graph.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 graph.gif
M1TE&.#EA00':`/<``````/___PH&!P\+#!,/$!82$QD5%AL7&!X:&R0@(24A
M(B@D)2DE)BPH*2TI*B\K+#@T-3HV-SDU-B(?("8C)"HG*"TJ*R\L+34R,SDV
M-T5"0T1!0D-`04(_0$$^/TM(24I'2%)/4%%.3U!-3F1A8F!=7CHU-V5C9&)@
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MR<C(Q\#`OZ2DHR`='2HG)RLH*"XK*S,P,#$N+CPY.41!049#0S\]/3T[.SHX
M.&9C8TA&1D=%149$1$5#0T)`0%534U-144Y,3$Q*2F5C8V1B8F%?7UU;6UM9
M67Y\?'QZ>G5S<W-Q<7)P<'%O;V]M;6UK:VMI:6AF9F=E98*`@'=V=OS[^_KY
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MS<S,S,O+R\K*RL?'Q\3$Q,/#P\+"PL#`P+^_O[Z^OKR\O+N[N[BXN+.SL[*R
MLK"PL*^OKZZNKJ"@H/___R'Y!`$``/\`+`````!!`=H```C_``,('$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FRI<N7
M,&/*G$FSILV;.'/JW,FSIT]FSD1%HS&#1C11SL@<?3;#I].G4&?.H`9+TR1T
MU-(I0V'OVXH6L49%'4NV[$AGZ))AZ'.,E[(_%Y+U,O1@$RQH`99=":=#G-^_
M@`,+'DRXL.'#B!,K7LRXL>/'D",C[HNMZ<Q0^HSY6@&(0A\6NEAL`@8#T"5N
M`<CP^N"A@^O7L&/+GDV[MNW;N'/KWLV[M^_?P(/GUC!L&LT:]X+52O9A@(!@
MTBPA.@<O@0=T`9RU`+#`C_?OX,.+_Q]/OKSY\^C3JU_/OKW[]_#CH^<#(`0V
MFF20K%:$ZT0!8]948L@Z]2Q@R#D!-,-)`K^`X^"#$$8HX8045FCAA1AFJ.&&
M'';HX8<@AH@A$0Z(<`U-S_B@R0`*%*,,"(W`P((ER5BR@23:)$C"`^^8Y>./
M'IW2!R,GSB2*,((8,,$B,;RPR`+&$-%!!90`X4QVCC0`"Y!<=EF1.Q",4*1,
MS\SS@C'$_"*&.+M(TH,6PR0#CS0".9-E+%Y*1`8]M)C33)YCK1+FF&/9V0">
M@#JTC!R9``(#.34D^I2@8IIE***2+K2-'2`8@$$QA&:J$Z6A0G6IJ`HQ,P8D
M?!```"'T7/^)ZJB#6GKGK`B%\D(#S@&`P:.XYD2JK8<&6U`H0$!"P`.$\,$'
M(;Z(8JQ-PY9UZK0"@6,,'PA(DD\E$"2`R3?8TE0M6=<:ZT0S1'R`P"'TD!'&
M(P5@X,LVY<IT;J&W3AN%-LHT<`$+Z#!#13`-&`#)EOG"M&]4Z09;#1&%$+`(
M/M0(I`HF%3@@B18T-.R2.8(L4NI3$>.:SB4)(,`"$LL(5,T])22P"!%(B-P2
MF)5:VR^N4[G000*)\`/%0,Q40PP#!T`2A,XJD8$.#`NH0`JQF,XJ"A":3.!!
M+Z@5%$0B!-P!`S7,$$2#-%90(XTSS"Q#QC.AT"!W*-2(THPSTM3_D#;4"2W3
MC"ALP!`(`2A8@[6QV0S#AP")J".%0=OP<K@*]-`YD#HP0`*),O.(,H,:LN!B
MS@S=[+())?+<`P,_Q@&>$#G"C/```0*T<,7BN-(0CPH%4`!#-`<QHTT,#?#!
M0CI_!Y"+!0;P`8$GX%R3"R<IY!--$2`@H,%R%ERBA>P&/6/-.\;T,<`"MW.R
MN\_%SLH,$KY(P(`E\)"!4#/])**`!D5X1LP"\(($5(()(M"`/-2!B3Z`8`A7
ML,0=$O$+>"A#`9R00_/(%X!O].(1&"B`!3J1C`5$X@:\0U4T^H>`#[2""@KA
M!C`P8(!&Q(-X`2`&`B@Q!@\X`!;X`,0`__`P#'5<(A#&&`,N4G"`$WAC@U!C
M1C9Z``,03(`!A"A&&H``@1"@$'Y9RQ02+'$``[1@');9WSI4L+Y.C"\`O[C#
M!`[7AWOH@SX$.$$_>%$,7A@C$A0P`":>R$$K\`,3W'I`"_HA%G=(8`17`^.L
MH!&$#@C@$&[0G$*@$8P,$.`0^8A4+28````<(!(NP`4D/E""3$A"&,3@A"(>
M$0@$7*(;`X2:->0A#!5<0`^)2(80OM&-(+`@`9%0G"11-8YB[$$/,/B&K!1"
M!G5T@@\6D(0.`C`&]2$@!,D01BYFT09U^&(3*\`$`P+!BV,(8A(Y`QPU7I$)
M"2#``9K@QSBZ</\/912B``+8Q/O0]3-)0:,7A;A#".H1A5QNL@XIN(,@A&$%
M;>3"&"\0`CM^D(YMF&$9Y."'*_0!`V"``QVXF`<.168%(+P`$ABX@"$T`8-B
M&(,2*L!``G"GNQ0F:@;E<(0!+*`,4T`$"<2(0`%"$`\H<C!P,\!&*RJ!@0,L
M``0L`$8,-+"`.QS``HD0@0$2YU-`8:,6?2!`"NRAR88X8QUD7``,NO'4AM``
M#,4HP1[N\(`^0*`/?Y"``O:@"$R\H!6]L(#5RIH2,C0#"LR(6T>8$806,``"
MP*B&_AZRC#+HXP\(`$$NG.'0NA+$&=4(PB0D8(`!W"$0S9H`!<(DB2;_D.-*
M.BC9R9R2LI1<(0W3@`)I.P(-84`@#YN(!Q1*VQ!S>.(!#*"$-S9KVH*(8QB*
M",0$"C```A!@CB2(02Z",`YL3$$@Z(B`R1A;DF5D0QZ^*$8OB$"+?K@B'JKH
M@3J\@83^8F,4TI!&-)@2V30:!!KQ2($!/D"$:E!$&O>`A`$$\8NP57<9U1@'
M/&`@"`$0P``+V$,@^J`"9;2""W\JR,-,5="3&*$?D9!`\C"``0A$(!`>,`$(
M)L&+7_3"#:U0A2K6(0<K!#AV!^&&,O!P`$IP@[D.F<$TAG&'`:3@:=4-`#3&
M4(D0['4``SB`(!YAC'ZDHQ34J`%S5XRR%I<$_QI`$.H$;MR'#&!@#PRX@P$H
M0(@4%((#'X`$)C!Q"4D48QC#($8O^,$/?01!%>0(!SI^H0$$]$$8U7A"`)SJ
MD'=`PJJ=T$:*94<#;:3C'K]`P0($((`%;$`$F!C&$,HQ382PF;=N)LDY.K$'
M!$"B%[.@!2^`\0))M*`%G(!$!Q10@`/(<0*R90`>INT`/CA@#XO`1$TG(0(&
M[`$%P?!!*4:!#2N,^B%(Z(<B[C""(F2#?&3HQBP\\8$]*``!`IA`(H@QA'!0
M`QIP6\BM?=);D=3`"S'(``5"D(MM8.$:V^C&-]A1#WK<@P@OB`$E6(`)%#SB
M$9$0`0@*`8(^,"`!#/\0Q`8`(8@,,'L"@!"!(R@A"19(`@;#",8+@,$/=L@A
M%`J9`1R,X8`)H``(.CM#-MI1!&-((@40&```#+`!%!2#'SK(V$,&WI."A^0<
MRI#`!!C1"[H29!EH3[O:K1`.OZB#%?GHASY^,0E/L,`3):CJLZ'-=[XGX.\(
MN.HD?N$.L2C$%2HPP`6`005.SVH:ZN@'"P)A@#LD8`('F,`'B+$.,J`](ESG
MB=<_,@YC!$(!BP!&-ZC;D&4\X0F#LP8.2"$'=KC#'6"`Q0L2D8`[$,*5DL#$
M(U00B1!P``)[N',"%"`(%"CC%4E(2#9V$8$!*`(6,#16%NKA"TF0(!&`4(#_
M<SRL@60,X;84"?U.1L^1&9A"&!RX0R%\48J/+&,<RKC`KWZ`C2N`PP?W,`_Y
MT`O$8`QQ(@*7)UN0H`OB$`W#51#:0`F6APFGDRER\PRB@`7N4`N:D`%W@``'
M@``4T``4X``>\`+W81'JIQ/LMQ'74`LC@``/,`GE$#(>`0VYP`@)D`)`,`TQ
M$Q358`77P`W@(`YJ4`ZLX`M;Y5V`T`*_H`[,50:TL`@(@`A%@#9B)`\O<`F+
MX`$+8`![4&^X<P<:(`G]\`U0!A$KF!,MB!$TD`U%``D+P`>6,`^.=Q'-``21
M<`=]\`)`YQ`RE`@+`&V`L`+WX`W38(/9\@(*EPGR_[!2/[(,SA`-2(`.0?`+
MF=`'7N4`#]``(``)FL@`B5`,7:`1:X@3;7@1V$`$D(`'?'`)\:!U'J$%OA`!
M%(`)\'!N"^$,V]`.O[`)?%``",`(,1`$[S80-?`#D"!1Q*!,0$(#W-`#QA`"
M?8`!"(``&,`)!4@"@+``]<("]>`->)$1IW@29,`-I6`^ZA`$KQ`$K"`#\,`-
MSU`GN;81SY`/D9!YF2`&!L81ST`$*C`!&D`$5G"'"3$-01`#(#"(&&!UK%`*
MLF(#OF`([/8*2#869%`-<@`$M)`,EQ!U!(`!&O`(,1`,P?!T$A"&Q[`.'5&.
M)E$-P.`+VA`$)``!#8`!+O_'","@05@2/R"A!BPP`0-P,="0AAB!#9X@6YB0
M#OWH$$IA"O=0#(J0,,C4"W(@$,M0#LI@`17``JM@%DC0"L0`BI<7>"D@#/`@
M#NM`#(5@`);&`K!@#7^X$2XY$F20#40P`BU`#L"0`$T(`0<0"(F0")F5'8W@
MDQU!!NX0`WQ@`(20"[+H$=0P!APPE/U@!1=!`^!`"Y0@",[V`95`>%40`.ZP
MC(+P`A?9$],@!T$`#)(`4X&G7K$6!-_`#6WP"XE01H0``S\0*1Y1ER+Q#*O@
M"0R@`N@P#!,P#-#0"1=#!'N@`N*0()R`F!M!`W(0`PQ``(1@!])@D!?1#BO0
M``W_<`S<4&L3L0PS$`IJH`N;@`$44``,4`E`($7$T`<(@`+JP'HZ,3_P%0D+
M@``3L"R<X`_U@`0APPVX$`G<D@>-4`2EX'D?`9PA00,Y``P+4`CL\`L.0`*]
MP`B+(`<]\%KI()W4J1'6%(R%D`O1%Q*J`0@*U0KZ>1%:0`_#@`(,,``,\`C#
M0`1%D`G82`SAL'[>`%\KD`@>@'D8$`F&=0](D#8T(`^3<`@*@'J=0`_Q!!(2
M*A+HX`&$P`[ZP`@38``"T`'XP`_/&9T*4J)XB`3&4`$#8`BZ<%XA,0-R<`G8
M:`Q7Z1'2``^=L)`3H``A(`SY-XRS`*$SL0S,0`8UH`4^_P`,FM`'@31G.BH/
MVC!`S+`-`,E=>U`"18`O(Y&E(5$.@%`(ZR`/CG```"``%;`!@UF8SG"88801
MV=`+@:"JQ1"D(A$'=@`(!%`"/3".'C$-YS`$R1`"!S``@<`(8E<!G;`-1KD2
MQN,#PG`"(M`'!W``$0`)++`+\A`.2-8,JP`#,4AUQM`*E4H2H`H2WF`)*X`*
MX0`,D!`((:`"#P`".YDVJ>@0-&`%M<`(!L``*X!&(C$#]/`($\`'P*"+'X$-
M1?`(#'!%$$`!!R`"NL"3+D$&T&`%<@!?GA`(!6``%;``(W`,8B`'FC80H0`'
M0D`)$(``>8`"N9`C)I&N'P$-Y_]0#M``#=S`#O+0`ZO0"O(@C_2HIA11#;CP
M`2(4`^XPE_8G#<```0I0`EAFETBP#KU`";4T`$K2;O/H$M0`!+M0"2/`!UW%
M!RH``[W0K590:V4`!L.P"`WP6I-`#]N@B.A:*\N$$:.0EP4P`96`(",Q#?)0
M`@;@`;@@LR;1#.Q@#(FP![Q2`)"P#^305B3!#-!P#>8@"[YP"7^@`+(5`9$`
M`T,@!V50/MT0"Y>P!P7@`"I`#%Z@$C3K$OG*$*VPC`J@"?60FA_A#<?0*B<0
M#@HK$LL`#:4`!#!`"'IV!XN0##W0M24A#>C0HQ+P`.)'`6=;"ZJ@#6O+7-X0
M#"J`;P__`([:`*PG$;LM,;L'"00M<'DH\`KD^Q',4`/Z0(6!T`O>*1+ET`LE
MP"L&$`B5(`SQL`U-J1'.H`WG$`O"<`DBL``$L``:L`@L0`3BH+M8:0JN$`.%
M,*4<``,]<+]8BK<$1;00`024<`$)H`(XX\$6\0S@``,7L`<QP`[/*KS-$`VS
M(`(-@``)0`'(5`N(RQ'0$`ZT(`D?P`<A6"*2,`3J@`700!0(<0V^,`(*D``9
MX`GX4`UJQA+FRQ+H:Q#1X`.4@&<I@`M7*A+4<`N,@`"*4`_2\A+:$`R5&8(#
MD`",(`E%L`X4'!$S8`WH0`2=@`D?L``'<`$CF0S]H`J&EQ!6_R`&QW`X=Z`"
MQ]`#3+L26[P275P0Z_!<)TP$Q]AZS&`-VN";$$$.FD`!?-`)9>P2X,`)!;``
M?8`(&#`!"<`!D\`*U3##"(%VTD`.^7"\(:AG@#`)_)`.>7QV2!`$F-```J``
MC2`+GOH2E:P2ESP0I3`,$E``@C`,J:P05*"%F*`,Z@`1RV`-1>`!"8`"L!"\
M*U$#N1#(GP$#P"@`"0`),-`*%N8058`.0F`,G%`(UI@`&^!*M=`.V&">!T$#
MZC`,)4`!`X`!DG`/<*`O(,PO(APXUKD+(J``$-`)X<P0BKH-K9`)>```#&`,
M6J#.!E$#0;`)"A`(NP`S,K$HPB`!%__0"4'`IQ=P``KP`"4`#.=@;H['#,U@
M`UB0#DR0#/2*>0Y`")Z0"^;0Q@NQ#,\P"O40`^&G`(4@#/?L,!,-,?6X$*7@
M"XJP`!`@":D`U0IA!?.0#",P`0(```2P`;V`U@HA"L>0G8G0`RB]$L\@#R)0
M`!(P#%J`"K@0`VU=+YF0"^-@MP0Q!=[`!)T0`G]@`=\%`IE0#/J0#EKP!@]Q
M#L0``A0`<RLPNHP-S5W-8A5]$,N`!+BP"(,\"2RYB]F`#KR@"1!P!P[0`8"P
M!P>0"//PO@?A#.P0`@)P`<40231Q#<3P.(N`=`&0!+I0`@R``'@P`LJ0#^)`
M#30@U-2`!)'_9PPH8`&NI7^.T`OKX(P-T0Q7``3)``$"8``C4`SE<!/1G!)=
M'`7U0+@%@`+M`(D(40J\@`(.@``,,`+#``NV4,K9U-$*D0._8$^9``3`#1,U
M8`XL<`<,$`/S70;:(*TM(`%RQ`$KT`K8\`S;X`K#\`C=*,M-"`Q#@`Y($`TQ
MJA#:,`LGL`<&H`>;T`_A,,D2W3,A'*MU'02:H``'H`CZL!!4(`>M8`QI#-B9
M@`OX(@W\(`)\.`R=?-#],P$<0`31H,(J$00B@`"`\`MS>0UBD`R*D``%\``H
MH&C&4`*W30$78-F_0`^[M1"CL):*X+D<D`R_+2RGW6:I31!/H`Z9_Z!GB3`$
MW9D0,Y`.Q`"W$_``CH`+XC`*'S4#X=#>"!`)\R"G!W$-DJ``=[`)J3`#3H`3
MXM#>"I`)Z-"U-``-VQ`/G<`!I)X\.4P`>Y`)P'`/WV`%38S+!5$&]H`)%W`'
M%1`)O"`'TC#`/Y[G7??5!=$,\4`)7Y@(_1"9!6$%Z.`"E]`J"Y`"G6`/6%`0
MSM`#E;``"M`"8H`0TM`*C/"F5Z@3T-`.)T``%E`,X%`0S$#;EU`(%L``ZE4"
MQ%`/I;#7"D$-/K`+*8``!:`!+#`$*THK0$[10FX0,_`-$F@`B:`/S>#L59"0
M&J```G`_E$H&4,0,-/`**2",DN!@!H$.RO_`!Q2@#-I@!CJ!GK^`!P/P`4-0
M$.A)`]]`!!HG#/7P<]LM[`9A`_-`"6E%`(RP["C/$_6-$JD8#L70```0"/ZP
MS0*!!+!@##@\1Y`P#&PPX0.Q#;[0!P+0!PUW=J&`"X1``8K`!$K_$NMP"5,J
M"=P0O-FP#N\0#I0K$>/0"XUP`8I'`K.0`TY1]2?1@C-0#<'`JWM@#-I@MW+C
M#.)`"R7@`*XU`B]0,`SA#&HP\]_4#X8*#>B0Z-E,+JH)#RB0`!^@"V_D$3,0
M#>A@#!NPPWY@#,PS*8..:ZE="L``"`60`<60"C$*#D5@"89@Y!X@"4(0#LZ[
M$%+0"HV@`'DP">/_T+5(\`M1EP+O@/8VP0S4L"UW``GR`!+DW`AY8``-T`B]
M`"E0X?@F,7HT@`/%C^\P`!!(`@P,L`R:M1_$0BRX`R$%+RT$)4ZD>(V?HCN`
M7H!;1D9,)`1\B%6A6-+D290I50X4TP+!A&1(:*RD26-:.5LA"@P`1"F(-)I!
MA0Z=N`K"B&M$E2Y=Z<Q1@U@GJ0'S4.`!BQ\S"3YI]R(2!@065`23MZT941K8
M.BD@$*(5F6F],C3(1(\94[QXJ^W;,,`0+5%Y)5IC4NG/`00J;*D;M4SP8Z)&
MD4*F/-0I5).CAA`:0(&2*E`#EUDYE\^2H#L._JSH1RIOO$8&#K"XQ^^$_X%"
M0JI5YHVR6J<%"%"P"XW7"35PO$HPN(.AA9!GO:6?E)QT^G6)EZ-2)-/J1(($
M)&0`'0BMGJ="!PADF"2KU"BM3$7=&S&@SR-(&`:@.$4&^W5GAH@D`4!XP>8N
MIJ2`!P8.)E!@D6'6H0;!_ZZKKD+LM*/(FE9:T..!$YBP82!L@""FA`<08&"$
M8G8X"[)0@A&$N0DJ".27^##D+8E>`)F@!%A"6<H95(AHP0&K6M!%#AW_N[#)
MWC24:(96-FF@@A-DH6:@*_0I`8$"&"`$!GFL:89"P690)YD."BC`#QC201/*
MQ\A(IP4*^.ADFZ7""28$!`3@0Q)WK*#!,3I[>_\R4<BD'(@&<SRIP(`1]IGI
MFR)B2`2!`0*9)!=SG)&NF7@2$4``1HH8A='*IKF%$008R<>*H4KAIQ(.%+!@
MA!?<*8-5Z18%%B]'EPE'&`TR*B8-9L@QIL$)%DA!%R3\NXZ<$@08@!!AOD$4
MI668F6$&9I999EQRPQV7&7;%7??;@MHUUUUVYZTWW'(#:%?<<I=Q)AP8]G#`
M$R#@/6D9&JKI!00$"(Q!'F<,'O8Q82=6ZC)9!B)#B6%`<("17\Y)IY9,'!A`
M@1)@N*>4_T1Y100!"&#@`UIF`#<`4W;)A(1?2H$G!A(JF84>6Y+!A(5A@`GF
M&$D\>2&(`P-H1IYB5@#_)AQVCJFD$V'NN<(:(F`@II526OG%'&N&&.8793(Q
M)AY::[A'A`,D$"8ZE:@)(AE!!K@#DA?6(<_BRBHF7*C+8`E@!G&01:"/3N!9
MQ9A"%+#JDGJV_&^&>"H1A,`+!B@!'5%-<DP>0@`@(!)_,B%```B2`6:$"28`
MY!%%^#A````P@"&<&9Y1YQA&^B@AET[N4!T#3(@8HI)%%.FD%A0D(,*<32;8
M(X\$!*D$B+NR(0:#`E)P!^^2EGG&&R%:6$"`!31YQ9K#%3W*NOHM(\$!5@*8
M)I=%W($/F`"&)!;A``7T01.^8,>J*E2#86``#R,@1B8*T(!DE.-@,[B'("CP
M_P)A$,)-E?"!'.H!B#V\@`?GD(0!`/#"/A1#"\MPAS(D\0)]%&$2'$#`"RL0
M`D8\@AA$<$,QK(2'Q:0@9BG`A2;X8(QI2`T=%EQ`,LYQL'4<0P44($`?D@$/
M:\PI?WDQW!A3XHQ&."`(T!A""B9P``Y<PA,0&,`$$F$,=D1!1\]@1R)X$@PY
MP,(0!@B$,*Q@K8D@K!6`D``_<M&'`23@!5>`A@\$`8%^C&(:G2B`!3QP@`WL
M@B2[.(0RRG&%5Z0``0+\PQ\P(``,]",*5_B%(`2@@%FD(Q$`$``)Z,$"!G1B
M-P,90B$,``A?U&!.SBB%$"@AB!J-`!C<,"-OREA-D_\X@Q-X$`(Z'J&`!T#`
M`QAHP`(((8E6G"(:3?)&,""`@$RHXQGAD,0>$@`)5S@PD32P!R,&L(`2%`,%
M$WC`(W31BSX8@`.84(8&8((+#/1A"'<1!@1>\`TW;&($##``)X9PB3L,@!%C
M:$8U@"$!`$Q`'W)0!``*L``(W`X?\2D'#"3@&7"4CB#=(`8@5BD!%K0""3K%
MIF"N6=2)T`"DE8A!`P:0!P?@H0$;:`$NS.$$*#EA'R&80`=J,9-G@"$3"\!#
M)N)ALT3.@!Z+*(`$DF$.8Q0```/`!`P\P#L$>"`!#W"%'#X0`2'<11\H2$8P
M4``!/H"I&*.8Q`"`"@PBT(+_&)A`1!]8(`Q.0$`!"NB)+/`7`&@L(1-WD$`Q
MOO&H)`3A&!D0``(2<0Q5(+5P]Y-M2L@P"0)0``,52$!("Z""6J2#&L^0&':J
M<`P\4``3[K@+,T)A"Q`<``+"N,*<EN$$>"P"!/*HAC5B,```((`2PUB$`?[)
MB#T$0A_H2(0&B`"-`&2C""T`!",\P"D%O*`4FB#`)=QPB>C!H!7^.($>,'",
M8F0@!?:XAC00J:]G_$(_'MC.-MQ0`MUAX!*OX$8-BEO;R-`6Q":9!@L&H"T#
M+$`"B[!$/S[;I%$P@1$$8(0^:+73%^QA`!_HQS`)XAAN^&(6`V&&*U:@"67H
M0QZZ_TC&"F#@BQ<`8QS9<,,OTH$W;=A"$L((1M.,\0YJ$$$28OB&+91QC'M0
M`PFP\`0E?"`.8`SA5R99AR7`)(D>!,$8(TC`!$!0#'BL<\04$_&@)0(%=+2@
M``9`@`&<PP]LS.##_W&')NXP@4Y$C2`S"(<%#=`('Z2/#&1`U`QHT`P:D(L,
M-&#UJLE0KE%3B!F?H,&H:0`*&I3+U.2:P:@E+2Y6LXL,DCY)-?"A`@2(X!*)
MP,`=+E""6LADTH8.RE&!U0P@`($:-?A&`7N@A6%\453DZ$0'$(.!$2@C'_I,
M5!EFD5!"]*,D91@"LAL0`W-,6[;,L(8Q^-``"@P`CC%XA?\VJ`T9:S-J!CKP
MQ"3*80YA=&`!QB!"!RI`"3FQ(@460$!>*3&+>(3C/:&H`:K3]9]0C,,3"CBP
M.4Q""B(L`@&!&$8V]"W;(&3V``9@1#"Z<7#*))Q.S=#!"P"A`GOXX@./@`$+
M+)$,2VP@&=F00S$^4``!&&`/'T@$)%!P"6/D8A[HN`;ZKK.-%^A'!>X8W$1F
MT(UD-#L2\C#[P9'0CTNDP!-$",>#@8X7H4.)CY-0@`>*<(D"&,,:E3#$.NIA
MSG(\H1PMT+H')/``YC0,`XQ`,B_T\8-S=`,;5K!!R=&:%X358Q&=(<;I3>*#
M2C#``2OH`5$//@IZ",$;-_][M0O_33AF4$,(&!#$+#(Q@&)(PQ*(.`<\$N`!
M=/AO$Q08!CR&\((8:"(%A=C#!!!0@9AN8!$M*`81P%`.)+2=*3.PAB^:C8)[
MJ&0:^P`!`1YP#'8?G`RCL$;=>P_XWSN<<-@`0&`"H\L$76"!30`&&`"$2_BY
M`."$!YB#@<`"<8`'??@%28`$/V"D/5"`5=H#99.$8?"%?1`#=-`"4J`&:#@4
MH8"&5B"!!"B$(L"&E<B&%X```0@$6GBQ__M!,@I`PCD'0EB$'EB'9`"$"TB&
M7C"$!^"$,8"O9G`$!VB%1ZD!::`&:]B&<HB',;"#+GL$'2N`!%@`!^"#/8B`
M$_B%(8"'_W/(`D&C"6M(!GMJ`73(D9.H@36(@01H"R$`0D`T*B&T&"0`AE[(
MAAI`!V5``7OXAA5H@5AP($<I"3*H!BU0AU<P(DA(A$78@#Y@@`.@`$`(@4:P
MA$XHAET0`G@HAVVP`FAX@I(PCQ%`@`_`A3A<B7AX!$:SA%.PO4#\Q94(/#J9
M@5`(!7*A@6@0!6<@@V1\!K2:Q$02%S)HAF>P`6K8AG20AW[@A4YHA`PX@`.8
M@`2@``K8`PUH!!BHA7E(!R30HXDPAX#A`RORQ8/9!EQ8A`DPA%Z@)F#LQV`<
MQ$&#1IIXABLH!76XAP*Z!$>(A`_H@P?(`SPPQT@X`4KH!,@2@_]TR()2"(8V
M,817$!*AH`%N.(8]N`,5X`?X\D>5-`EAQ":!7`I1$`=VR`=?F`1'``0%N(,^
MNX,#<``00#(BJ(5$*(`[L`1P6`I6:`0'L03!64FGE(B6K*:77`HR"(5KD`-V
MJ(<B$`9EH(062`0/N(`*8(`'X``-(``"4`%9B"*EN`(A^`!!,:VGG,NH-*.I
MI(Q0D(-T>`5>6`%(``0^8``&0`!"<(-I<#W+&(8*(`!"L`-I$*.Y#,2Z'*.[
MI(QF0`-K*`5T^(%7F(472`:G*0?(%`HZH(0*F`!'J(<7B<Q^G,S\J4SL@`9N
M*`<Y6$VF"`4@.($)&!ASL$W6!$37K!__V+P.9G"&4"`NP6"&4?"%0KB#/]"%
M;/A-8`S.PQG.00N'\3D`12B"&Y-.(*1.PK'.$6L&=(B-`]B$=/!.X`3($1//
M$9."?:@/!8@!#5+/_P-/BW%/$"L#*^B%"!@`"``&W[1/0\//B='/$2N'&+@`
M`TB!(.A.`BU0]@0Q!`4Q:'`'TW2`2P`"Q(S0VC+08:G0VEH&4:"%`.H#8(!0
M#_W0":TM$06Q;W@!03"`$."'Z#2)&D`";"`#:-B&49@!4;@&:H@8N#`%<+B&
M:$`"<2B';I@&QX"&:[""&JC*;.@&+1@%OUO1E`!18'G1VJJ!<N"$`1B`N4N?
M`#B'9!B&:F`'_Q8@`FJHAV#0A_ZX`EC`!$80AG>`@4+`@!-P!3,(`'<0!B(H
M!VI0!V-HA$H@@FK@/2T-`"YE%2\%,2(XA*R+`6W`PW!I!0[P`"$H!@9@`2X8
M!A'8A%FP`E4X@07(@V3HAPT``#Q0!+,J`R((`4YX@5H`!DN`A$V0!%I@DD95
M"7:0@,GHO4BM+3GP!4`H`!!P@Q=C!C)XA3]H`$J`A`FHA#!(!@_H@TGHAB$(
M)QC(O0[8`QD8`FVMAEG8@$-(A!&HA")8!R"(@108@E]5B518,1\TM&*M+6V(
M.PJ`A%@(#()@AF80@@Y`@$@@A`,H`5\H@=T9@7=PA478!"*8!190`/]&6`9N
MN(,-F`=EN`,#N`,"2`1YF(8>V`0,Z(5Y)3)8#`!GF(9JJ`9I:(4]"(%[#<BG
MV(Z5[(AZP`0+X(-)8`>=8@8:8`(.8(!<]3-**`0"``!#8`)T\(5@$(9,@"1&
MR`9TX(-"0@$W.8`!&`$A>`=BZ,0BF%<RN`(M2((LR()Q`((@N(=5$(8*4`'Z
M(=:;C<Q1R`="(``,*`8^(;(9>`5&RH5C8(`"V(-(H(02L(1:$()@V(0_@`1'
MF``#<`1)*`%(:(%*J`1,4`0%V`-*V$!`\-I`=()\J<1M0`(DR`93T`%W!0(?
M:`=Z(`)@*`8$,P9E8(%+N`1+J(06@`052(3_2&@3%+B"_\M7$%.+!1`I(8@&
MQS`7(-!5<:`'13"`!GB!./`")AB"73`&$*"`3L"'1]B)1<@%7[B$6N"&;Z@%
M1_``%;!<2/"$'Y"M<T&7<2$#4$`U&JB!:N@&<CB'<MB"=("%6B@"(B`"7<`^
M2J"$AMN$0\B#.UBE.XC@VIE@<00/3FD!XJ5;S(A,,EB'2SB``D"!>J`0;`@"
M>`@%:[@'7\@%'6!9;)`#<UB'?O"%'<`">?B%(<J!4Y"'GV.&;8@'?A`")F@%
M>UB%FJT?:\C*,6@%>KB'8*`$W;6$2]`$$H"$%(@$*V8$#NB`#N"`0,``"Z``
M!:"`!=@=`X"`0,@`_S0FA$0H`11XA!(@@4N0!"/ZF[G].^,=L7A0`0)(`$_X
M!CQ4S^`1A6Q0!2W3A$=H!$W@A/\D`'`$QY<`CP088ZER`$O6`S3$`$WF`SZ`
MA&(`AF$H!F'0!2&8!R"(AWF`!W/`AF6XAYEU#0W&V<C4AE_@@`/0`'\P.`^=
MAG0@@A58A#YH`._K.#`Y``SX`$(XA`U0!$[8W4J@!!9(AA?XA6`(!F#8!2(0
M@E?8YE?H@6_H!F_X!CG0@FO0)&H8!6HPQ@#H@1:5K3S>SZJ#@`10@7X(!48-
M1"FX!E2(AUQ8@42H@)?J`PX@!$+0@$)(A$L8!CLX*%\@`GE8!W50AU0X!_]N
MF`8I"(5H"(71I(E@'58\KMO?5)]Y<`0%:``6&`=Z7,DGZ`9:\`1&@"8$R(,0
MB(%^D(=T0(>;+@=OT(9KP(9LR(8KF(9HL`$;@`9H<(9?8Y>\<(=V1JIW'C$K
MZ`<10`#?(8>Y=`9K&`=6T$`1:``$:(`^2(1)(((N&-!$>51&>6H0FP%L(`8)
ML(\A<\IE\(8Q@(&%N+2988$B2`5LD`9GV.@F0>M$4>L14X<84`#1\8%`_D%1
M0(=8$`9*"(%F*SQ.B(%:\`$?.QS!IA/"!K%HZ`%'.``\8('H"T1FT`9Y2(80
M0"`#4``.8`%:&(<?-9<QVFPHZ6S/[H5D<0!(&(;_;LH!MJ0V:0`'5WB!39#L
M.Z``#2"!9*B%=D""E:TFVVX2W`8QN`(!\^+M9/"%5V"';9B&HVZ&3P!L5NF(
M&H@&.6B%%W"$/2@`!'B`#LB$7DB'6RRJZ=:1ZJXM*E@'8F"$Q+H#/!`$0E`$
M%2`@>4`';#B#:D("62B&0?B`"W"0#F@!06V''`!)%O7H,2(#4>"&<3`%%AP%
M</`&:4"4_*ZM9L$%8T"!#>!D!I@``D``#L@$9>B%-DR';K"&=&Z&>[9,:<@&
M<&@%8'@$L"A#0&@$7^@!*CBX^\Z+*[`'3%@H(5`'(E"$N7LUE@5I#PV%*DT'
M5B@"8(@!3E"$SSD`!HBH__JZ!%\8`W38ABRMD&V`!V$X`4'@@SX+A!88!EA(
MA?3K<<UN:D;YAF$8@=<F@A=`@3X`@4[H@9DX<6I;!FLHAR#H!V+@A#_H``FX
M@$:C@`V`A!4P!ET8@AX(!R08A6A8;,&(AFY0!WTHAA9`!,F]@$6HU7JPP?L$
M]$2!1V+P@5$H!Q*(`%^@!16`@1K(\@V>5X3!0FK`!FY@AWO0A6+`A!'(@P((
MQ09X`#Y(A$ZX!59@1__+"QM(!V&XR0<X@.8X@1<0@W*P!FE`]4%K<KP8!V+H
M!%MP!UC```50!7,(!$>`+T<'0F8@A7"(AR)(AD:`A!#84PH@J$,H`4R(@6)P
M@?][2`4YN()B)XIHV`9WZ`<8R`2]:@A"T`1B"`)?E4Q<IQ,MV(75CH08V`,,
M"()X``%*$))__\%S635GB`8<\`8@T(<N`X$[*`!Q5(`)P`"Q_H56(+LW/PEI
M:`=:J`2?:AC#'?E2D`;Q]G.D@G>FR`8B\```$(2.3P04R`1,Z`=1J7E_=(9J
M^`9VF`5C\`1-@`00R``%,``"401'N`0F=(5W``=LH$=L@`<[6$0.J``!"@&G
M&0-R&!&5U/JE&(5Y(`$\<`0AJ`=C2"]:L`*;0?NYK(%3Z`$B"(83``L*Z+,#
M4(!`>`1/"(9^Z`$YF`94:X9H,(=^J`0/H`">?`!%*(;_5LB"E/Y%Q[^8;)@'
M6IB')*@&<\B%66`9Q^#\N9R!)/4&@@<&8I`$34@$)5R`"L"`/U`$%*`$8I@%
M+5.!#3!\/E`!2OB%5QB'S';*X)\.YU=/&D""=<`'8<"$0H"`!L"#!P8(!1!$
M,*)00(&$$#'RR0G@\"'$B!(G4JQH\2+&BZL@C+B6\2/(D!B=.6H02R3*E"I7
MLOQ(ILH5.>GH]0,&(Y.*#7L.&*B@2)*M>N..-&MI]*C(C1V1,A5)TF33J%*G
MJHS&[1T_89Y"B/#4;]P,JF*;*O4X]NS3DV?7LHTZPYFT4=FXC1O';52-96WW
MABS+5VK:OX('$RY,EJ-9PRP#_RMN[/AQ8[^043*>;/DR9J:2,X\LJ98SZ-"B
M)VX>+;&RZ=2J(9=>'0"UZ]BRV[9>#7LV[MR'E\Z^K?LW<)2U5?L.;OPXQ>&I
MBR-OCERY:>;.I_^&/EHZ]>RRK8O&KOU[:NZAO8,O#UH\:/+FUUM&SUD]^_B1
M$>.&+__^8/>9[>/O3YM^;Y[Y-^!C^F'&'X$)1F7@90@J^*!1#%KF((05IB3A
M9!1:N.%'&$*F(8<A5N3A8R"*>")$)#IF(HHHJM@8BRV*^*)B,<K((8V&V7BC
MA3D6MB./$/I(&)!!*CCD8$4:22"2@BFYI']-_O4DE/A)*=4R,]0`#2AZ/41E
ME?)=*?^5',ED4@\97KXF8)AM!C!F4VGXXD$#DW@1RI=LNEDEG$P5`8DE,4`"
M0S9Y0K4GGP""ILP>P=1#2"(-.>0,"0[<@VB5J42P2&*<)8.!,*V`D(*DKZ%@
M`3R80AE.'YR*MD\C+512PC")D43`)2[HNBNOO?KZ*[#!"CLLL<4:>RRRR2J[
M++/-$AN#`8M@(QHVLW3`@#)K//-E)0(40`&XX8H[+KGEFGLNNNFJNRZ[[;K[
M+KSQRCNON@<`4((UHVGQ0@SO2!2/,I2LH$PG++`P20PQK$"))9<X_##$$4L\
M\24"2S*))Y[$H,S"GDBBC"24'"P)"Y50?#+*#EM"R<>2>'+_\"0+3Z),#"57
M(HDD)J>\<\25:*P,QAMC3,G,(1--\`J5-,PSSRM_K/#!-&<\R<4O=]))TDLS
MS3/15;,`PSQJIL:,7LN(K2J49IO-S`Q>+L,,,YA!$P0\5G@S#SK5!/"-,<`@
M(0TZ=OQRSE3+I,)*.C6408LQWP10`RPQR!*`%>KXD,94SPBA3"ME9*,..]L$
MH$XGO.0[NCQ3(>%")_&(HDLR/CP10`_)N.)$,ZL8,XPW4C$C1`RY@#--.L?X
M$DT9Y[13SC-("/-"*5-9`40;X02`Q##%M).-.<-8\DH9`<C12S]Z0[9,,S]L
MDHP<^FA2R3!%)+,'(,2\D`D(BR3#_XXT32T3CC%0D(E?%($1>("!*WR1`@4\
M(BLMB(0QNA$5*\P#!0DHP2V.T8(3)&,(DUA`!XBACAZ@P!&.8\HRM'"+$5``
M$[E8!!XT80M86&("CQ@#$SJQ!PPD`QTT8,HT@-""!7B`$L.@A`,,D8M<7,(1
ME?`%,2"PAQZ2P7_UH,0C*%$$84```S'PA3'^@`<6?&$;M^@#"L0QF5"H(P88
MP(0X@N$`/O@!`RKPA3`448$'3(()R2@&-U!(!G,$(P1ZX$,(+K&"1Q0B$"@8
MAB1$``@,)``20`C`V5@ROF,4`P42P(`$(!`(0EC">QT`P0?ND`@U(F49-%#'
M"_K&@A/`X/\8B0@$(QJ1M!9,8AB]2(8BC!$-IH##%[PH@B,8\``5P``&D/"`
M("`@`3[\@064"$0G:H#"4,A#$AQ@@`104(P8,`("&[#$"ZSY"THD(!+FF$PT
M>G`)!$""D!,0``$*$(EZ_.(.`&@`,>;1"$@0KI4T",<L6I`!`2`@&/0@!```
M@(EJ_$(``"@```*A#TPRI1NY\$41,-$``^33HI@8!3`&0(`%"(`1Y4#A*W]!
M!#9HP@/R^`8C(OJ(=\P/!;7HP2Q4H(S^(44<O\`'.23ASP[H(!X,N"@!#*#*
M6@B#`2>P`0JCH8H7I&`!`"@$..3Q5`+T8A2>N(,&`J%/=_SP,3/_F`8M\*`(
M=.0C$09`0"6$X0@]#``#+7C$'R@0B8*V$@E"^,4P0/``7]3#$!$]:44OFM&-
M9G(ET4!')PA!"6`P`I\FM<(P!J""9#"``X0]RC*P$01B:"(0(EC'-SZ@4S`P
M*@8>Q,0ONE`4I%##'<+`!"5:<(!`C`,>3RV``.X`MA><0`6_V!93F$&.6_Q"
M$HB4`RN\.H!=C$(3`%#I`%)P#U%8Y@<84(0Y6&$)#HR@'_Z8```@@(ED`&(`
M?(!!()MR#DF<8`66T$3,2K`!-`HC!HOH`P8F`(E4558EUH`%"`20"%RTX`%\
MZ,,?+"$,3FC@%D#P@P?0$95R'&,#=RB`_P0D,0P5]($0C0@9)U:0"0;L`0;D
MV.U1LL&/1"``$"0`!"%@4(Q(`"(#"MC`*\H!"0RP`!YM;:4,-)$)%FB"$L&(
M`0@PT`%/"&,3A%#!'Q"0@GD,<S+Q0`0*P'&/2E""&/Q(QAT6((D7>,(#$&#!
M*HC*%'U$```(\`0_])@,)OPB!11X!!&&P8D4'*-42$%')2@P@`N40,HGZ$0_
M)L$`#Q3#'.P0P2+($94B8,!;^2R`?',AA$LD0!/]0`$!&.H!7T"#*>S(!!YB
M+5@2X`$$N^`%)AYQ"5L`@P\4Z`0ZJLB49QS#7GL01B\0+(E?'.,/%:@$$)"@
MCS[4,VZ3Z89,J_\1#B'(PQSCB$4GAK&#5.0C&,'P`32\S90=2"(%FGA%-H11
MB1^<00N[:$$OJO&-5N2C';5N2@[\,8E)="(8_)A'*]0Q#5=HPAC,PP8N_$&*
MJ`"!!23PQ,)0X(DQ6`,:0LA$$;"1"Q)D8A+)N(<SF.(-7V!,$RSHQQ`P<8PT
M9*,>^*B'*EP1@TX$H1KR/DHSW*<"2:!C'"N8Q`^0@`YC9&)R`9"&+V@QBLLL
M@PQM8]L,X#8#&M`@[#,@@]<;S!)FT*`9S6@;&<K^-C*`(DU@)UM4LD1V&GA]
M!F'7.PW(UO4T187MS=C[X=NF=[B[G>Q'-TK7R7[X3XR=#&+W.]O(WC8^J<R@
M\7#3/-SBOOG!JQUMIC\]ZE.O^M6SOO6N?SWL8R_[V=.^]K:_/>YSK_O=\[[W
0OO\]\(,O_.$3O_@0"@@`.S\_
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>kissingersign.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 kissingersign.gif
M1TE&.#EA=@`F`,0``````/___Z"@I/'Q\>KJZN/CX]W=W=?7U\S,S,#`P+*R
MLIF9F9:6EH:&AH"`@'=W=V9F9E]?7U5554U-34)"0CDY.3,S,RDI*2(B(AP<
M'!86%@P,#`0$!/___P```````"'Y!`$``!T`+`````!V`"8```7_8"".9&F>
M:*JN;.N^+0(Q<&W?>#Y"W,,GNJ!P6,-82!('<<ED7BHF2*-)K=8@&=2#9NUZ
M2PV.RH+XFJT'SF&E.;N9'.!*\'C;=16)2UQK&.YO!GPM%@4P"1P4@&X<2BX:
M?R^($(MF!(,MF"V(!"@$"I5##1$O#74P/"<)&QP8H3J(<2]'5VTE%1Q3K[`<
MFBMK-1RD(P,<%[M#QEX%C<0<E,A"SRP(H#?,90&7NB\%T"9R@!89'%PH"KC9
M(M\L82/3-0J^`0\<AG?%O1P+!@3^GPPH<-@@@$0^;BL@N`J0Z@:'`28P7("X
M*(V^BQPL+.A4HM<%6BR:(;IG(P'):`&*_X%4,6``#P41,F+0$,Y$L37[4!)A
M9BM%/8R]-$284!.,&$$ZB>0K2H(9APKD%#`KR,+"!A$<)E!,FH.9!78I&D"1
MM^=4+`<G%VT5P0`8C$L*)K1XH.<"*0;SG-6,^92C"00K%9PBI@>'A%ZZ>.1=
M$6?>!G80('!B^#`%61-X$UDC\9)MKRSO>A$C8<"<"`61Y.D#PM<ATA(81(^X
M)(NR"G<H%"LB@??T,T%3!$U`2@`7GS`<-@O@8(O<TPBN8@$UC2*1)MHK`R0:
M,:'G":ASR*$5,6$#@0D]`BSXG//B!*<99?1H<($#@0U0>BW`&H;&@?\C]*:"
M8B;TLI5P$AUFP9EBVKEU&SFDQ()!)&%DX$@`$T0@P%8*^,7`!!-<"`1J(RQ(
M'0D/7)4"`K*1$)0/O61#002@//`>4]KMYP(!]?V15A4."+-"3`Y$=D)6`5CP
M@`#H[0=!!`XX:)0J'%!52G)F&#>,"O*,9Q-$"W(@@5\Z(/0"F5:0$X`$9G+E
?I@9B,+.6FUS%AI64=.K$3)0YY9GG:GX&BF8-(0``.S\_
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
